1. |
Further to the approval of the Compensation Committee and Board of Directors today, it was resolved that with respect to Item 7 on the agenda of the AGM, "Approval of a new equity incentive grant to the CEO", the value of the new equity incentive grant will be updated to NIS 6.8 million. The remaining terms of the new equity incentive grant will remain unchanged, as specified in the proxy statement.
|
2. |
The date of the AGM will be postponed to October 28, 2018 at 14:00 (Israel time).
The amended proxy statement and Deed of Vote are attached to this report.
|
Mr. Tamir Amar
Chief Financial Officer
Tel: +972-54-781-4951
|
Ms. Liat Glazer Shaft
Head of Investor Relations & Corporate Projects
Tel: +972-54-781-5051
E-mail: investors@partner.co.il
|
(1) |
to re-appoint Kesselman & Kesselman, independent certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited group, as the Company’s auditor for the period ending at the close of the next annual general meeting;
|
(2) |
to discuss the auditor’s remuneration for the year ended December 31, 2017, as determined by the Audit Committee and by the Board of Directors, and the report of the Board of Directors with respect to the remuneration paid to the auditor and its affiliates for the year ended December 31, 2017;
|
(3) |
to discuss the Company’s audited financial statements for the year ended December 31, 2017 and the report of the Board of Directors for such period;
|
(4) |
to re-elect the following directors to the Company’s Board of Directors until the close of the next annual general meeting: Mr. Adam Chesnoff, Mr. Elon Shalev, Mr. Tomer Bar-Zeev, Mr. Sumeet Jaisinghani, Mr. Barak Pridor, Mr. Yoav Rubinstein, Mr. Arieh Saban, Mr. Yehuda Saban,Mr. Arie (Arik) Steinberg and Mr. Ori Yaron (the “Appointed Directors”); to approve the compensation of several directors; to approve that these directors will continue to benefit from the Company’s existing D&O insurance policy; to approve that the directors who have indemnification and release letters will continue to benefit from the indemnification and release thereunder; and to approve and ratify (subject to the adoption of Resolution 5) that Mr. Tomer Bar-Zeev and Mr. Summet Jaisinghani will benefit from the indemnification and release under said resolution;
|
(5) |
to approve and ratify the grant of indemnification and release letters to Mr. Tomer Bar-Zeev and to Mr. Sumeet Jaisinghani;
|
(6) |
to re-appoint Mr. Barry Ben Zeev as an external director (Dahatz), for one additional and final term, approval of his remuneration, and approval that no change is made to his right to benefit from the Company’s D&O insurance policy and indemnification and release;
|
(7) |
to approve a new equity incentive grant to the CEO.
|
By Order of the Board of Directors
|
|
Hadar Vismunski-Weinberg, Adv.
|
|
Company Secretary
|
(1) |
to re-appoint Kesselman & Kesselman, independent certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited group, as the Company’s auditor for the period ending at the close of the next annual general meeting;
|
(2) |
to discuss the auditor’s remuneration for the year ended December 31, 2017, as determined by the Audit Committee and by the Board of Directors, and the report of the Board of Directors with respect to the remuneration paid to the auditor and its affiliates for the year ended December 31, 2017;
|
(3) |
to discuss the Company’s audited financial statements for the year ended December 31, 2017 and the report of the Board of Directors for such period; and
|
(4) |
to re-elect the following directors to the Company’s Board of Directors until the close of the next annual general meeting: Mr. Adam Chesnoff, Mr. Elon Shalev, Mr. Tomer Bar-Zeev, Mr. Sumeet Jaisinghani, Mr. Barak Pridor, Mr. Yoav Rubinstein, Mr. Arieh Saban, Mr. Yehuda Saban,Mr. Arie (Arik) Steinberg and Mr. Ori Yaron (the “Appointed Directors”); to approve the compensation of several directors; to approve that these directors will continue to benefit from the Company’s existing D&O insurance policy; to approve that the directors who have indemnification and release letters will continue to benefit from the indemnification and release thereunder; and to approve and ratify (subject to the adoption of Resolution 5) that Mr. Tomer Bar-Zeev and Mr. Summet Jaisinghani will benefit from the indemnification and release under said resolution;
|
(5) |
to approve and ratify the grant of indemnification and release letters to Mr. Tomer Bar-Zeev and to Mr. Sumeet Jaisinghani;
|
(6) |
to re-appoint Mr. Barry Ben Zeev as an external director (Dahatz) for one additional and final term, approval of his remuneration, and approval that no change is made to his right to benefit from the Company’s D&O insurance policy and indemnification and release;
|
(7) |
to approve a new equity incentive grant to the CEO.
|
1. |
“RESOLVED: to re-appoint the Company’s auditor, Kesselman & Kesselman, as the auditor of the Company for the period ending at the close of the next annual general meeting.”
|
2. |
“The remuneration of the auditor and its affiliates for the year 2017 as determined by the Audit Committee and by the Board of Directors and the report by the Board of Directors of the remuneration of the auditor and its affiliates for the same period are hereby noted.”
|
Name
|
Position
|
Mr. Adam Chesnoff
|
Director and Chairman of the Board of Directors
|
Mr. Elon Shalev
|
Director and Vice Chairman of the Board of Directors
|
Mr. Tomer Bar-Zeev
|
Director
|
Mr. Sumeet Jaisinghani
|
Director
|
Mr. Barak Pridor
|
Director
|
Mr. Yoav Rubinstein
|
Director
|
Mr. Arieh Saban
|
Director
|
Mr. Yehuda Saban
|
Director
|
Mr. Arie (Arik) Steinberg
|
Director
|
Mr. Ori Yaron
|
Director
|
(i) |
“RESOLVED: to re-elect Mr. Adam Chesnoff, Mr. Elon Shalev, Mr. Tomer Bar-Zeev, Mr. Sumeet Jaisinghani, Mr. Barak Pridor, Mr. Yoav Rubinstein, Mr. Arieh Saban, Mr. Yehuda Saban, Mr. Arie (Arik) Steinberg and Mr. Ori Yaron to serve as directors of the Company until the close of the next annual general meeting, unless their office becomes vacant earlier in accordance with the provisions of the Israeli Companies Law and the Company’s Articles of Association;
|
(ii) |
RESOLVED: (A) to approve the Compensation of Mr. Adam Chesnoff, Mr. Elon Shalev, Mr. Barak Pridor, Mr. Yoav Rubinstein, Mr. Arieh Saban, Mr. Yehuda Saban and Mr. Ori Yaron and to approve and ratify the Compensation of Mr. Tomer Bar-Zeev and Mr. Sumeet Jaisinghani; (B) to approve and ratify the reimbursement of Reasonable Expenses of each of the directors listed above in clause (A); (C) to approve that the directors listed above in clause (A) will continue to benefit from the Company’s existing D&O insurance policy; (D) to approve that the directors listed above in clause (A) will continue to benefit from their existing indemnification and release letters which will continue in full force and effect;and (E) to approve and ratify that Mr. Tomer Bar-Zeev and Mr. Sumeet Jaisinghani will benefit from the indemnification and release letter subject to the adoption of Resolution 5 below;
|
(iii) |
RESOLVED: (A) to approve the Compensation of Ms. Osnat Ronen and Mr. Arie Steinberg; (B) to approve and ratify the reimbursement of Reasonable Expenses of Ms. Osnat Ronen and Mr. Arie Steinberg; (C) to approve that Ms. Osnat Ronen and Mr. Arie Steinberg will continue to benefit from the Company’s existing D&O insurance policy; and (D) will continue to benefit from their indemnification and release letters which will continue in full force and effect; and
|
(iv) |
RESOLVED: these resolutions are in the best interest of the Company.”
|
(i) |
financial liability incurred or imposed in accordance with a judgment, including a judgment given in a settlement or a judgment of an arbitrator approved by a court; provided, that such liability pertains to one or more of the events set forth in the indemnification letter, which, in the opinion of the Board of Directors of the company, are anticipated in light of the company’s activities at the time of the grant of indemnification and is limited to the sum or measurement of indemnification determined by the Board of Directors to be reasonable under the circumstances and set forth in the indemnification letter;
|
(ii) |
reasonable legal expenses, including attorney fees, incurred or ordered by a court in the context of proceedings filed by or on behalf of the company or by a third party, or in a criminal proceeding in which the director or office holder is acquitted or if convicted, for an offense which does not require criminal intent;
|
(iii) |
reasonable legal expenses, including attorney fees, incurred due to an investigation or proceeding conducted by an authority authorized to conduct such investigation or proceeding and which has ended without the filing of an indictment against the director or office holder and no financial liability was imposed on the director or office holder in lieu of criminal proceedings, or has ended without the filing of an indictment against the director or office holder, but financial liability was imposed on the director or office holder in lieu of criminal proceedings in an alleged criminal offense that does not require proof of criminal intent, within the meaning of the relevant terms in the law or in connection with a financial sanction (Itzum Caspi);
|
(iv) |
Payment to the injured party as a result of a violation set forth in Section 52.54(a)(1)(a) of the Israeli Securities Law, including by indemnification in advance; and
|
(v) |
Expenses incurred in connection with a proceeding (a “Proceeding” - halich) under Chapters H3, H4 or I1 of the Israeli Securities Law, or under Chapter 4 of Part 9 of the Israeli Companies Law, in connection with any affairs including reasonable legal expenses (including attorney fees), including by indemnification in advance.
|
(i) |
“RESOLVED: to approve and ratify the Company’s undertaking to indemnify Mr. Tomer Bar-Zeev and to provide him with the Indemnification and Release Letter and that Maximum Indemnity Amount is reasonable given the circumstances and that the indemnification events listed in Schedule I of the Indemnification and Release Letter are anticipated in light of Partner’s current activities;
|
(ii) |
RESOLVED: to approve and ratify the Company’s undertaking to indemnify Mr. Sumeet Jaisinghani and to provide him with the Indemnification and Release Letter and that Maximum Indemnity Amount is reasonable given the circumstances and that the indemnification events listed in Schedule I of the Indemnification and Release Letter are anticipated in light of Partner’s current activities; and
|
(iii) |
RESOLVED: these resolutions are in the best interest of the Company.”
|
(i) |
“RESOLVED: to re-appoint Mr. Barry Ben Zeev as an external director (Dahatz) of the Company for one additional and final term of three years in accordance with the Israeli Companies Law, commencing on October 28, 2018;
|
(ii) |
RESOLVED: to approve the payment of the Remuneration and the reimbursement of expenses as set forth in the Remuneration Regulations to Mr. Barry Ben Zeev. In the event that options will be granted to Company directors, the Company will grant options to Mr. Barry Ben Zeev in a manner complying with the Remuneration Regulations, if and to the extent permitted by the Company’s Compensation Policy at the relevant time. Mr. Ben Zeev will continue to benefit from the Company’s D&O insurance policy (as in effect from time to time) and from his existing indemnification and release letters, which shall continue in full force and effect; and
|
(iii) |
RESOLVED: these resolutions are in the best interest of the Company.”
|
2 |
“Employees of a manpower contractor who are working at the Company” – employees of a manpower contractor, when the Company is their actual employer, and employees of a service contractor who are engaged in the provision of a service at the Company; in this context, “Manpower Contractor,” “Service Contractor,” “Actual Employer” – as these terms are defined in the Employment of Employees by Manpower Contractors Law, 5756 – 1996.
|
(i) |
“RESOLVED: to approve the New Equity Incentive Grant to the CEO, Mr. Isaac Benbenisti; and
|
(ii) |
RESOLVED: this resolution is in the best interest of the Company.”
|
By Order of the Board of Directors
|
|
Hadar Vismunski-Weinberg, Adv.
|
|
Company Secretary
|
Page
|
|
A-3 - A-4
|
|
CONSOLIDATED FINANCIAL STATEMENTS:
|
|
A-5 - A-6
|
|
A-7
|
|
A-8
|
|
A-9
|
|
A-10 - A-11
|
|
A-12 - A-87
|
New Israeli Shekels
|
Convenience translation into U.S. dollars
(note 2b3) |
||||||||||||
December 31,
|
|||||||||||||
2016
|
2017* | 2017* | |||||||||||
Note
|
In millions
|
||||||||||||
CURRENT ASSETS
|
|||||||||||||
Cash and cash equivalents
|
716
|
867
|
250
|
||||||||||
Short-term deposits
|
452
|
150
|
43
|
||||||||||
Trade receivables
|
7
|
990
|
808
|
233
|
|||||||||
Other receivables and prepaid expenses
|
57
|
48
|
14
|
||||||||||
Deferred expenses – right of use
|
12
|
28
|
43
|
12
|
|||||||||
Inventories
|
8
|
96
|
93
|
27
|
|||||||||
2,339
|
2,009
|
579
|
|||||||||||
NON CURRENT ASSETS
|
|||||||||||||
Trade receivables
|
7
|
333
|
232
|
68
|
|||||||||
Prepaid expenses and other
|
2
|
5
|
1
|
||||||||||
Deferred expenses – right of use
|
12
|
75
|
133
|
38
|
|||||||||
Property and equipment
|
10
|
1,207
|
1,180
|
340
|
|||||||||
Intangible and other assets
|
11
|
793
|
697
|
201
|
|||||||||
Goodwill
|
13
|
407
|
407
|
117
|
|||||||||
Deferred income tax asset
|
25
|
41
|
55
|
17
|
|||||||||
2,858
|
2,709
|
782
|
|||||||||||
TOTAL ASSETS
|
5,197
|
4,718
|
1,361
|
Isaac Benbenishti
|
Tamir Amar
|
Barry Ben-Zeev (Woolfson)
|
||
Chief Executive Officer
|
Chief Financial Officer
|
Director
|
New Israeli Shekels |
Convenience translation into U.S. dollars
(note 2b3) |
||||||||||||
December 31,
|
|||||||||||||
2016
|
2017***
|
2017***
|
|||||||||||
Note
|
In millions
|
||||||||||||
CURRENT LIABILITIES
|
|||||||||||||
Current maturities of notes payable and borrowings
|
6,15
|
498
|
705
|
203
|
|||||||||
Trade payables
|
681
|
787
|
227
|
||||||||||
Payables in respect of employees
|
101
|
91
|
26
|
||||||||||
Other payables (mainly institutions)
|
28
|
31
|
9
|
||||||||||
Income tax payable
|
45
|
50
|
14
|
||||||||||
Deferred income with respect to settlement
|
|||||||||||||
agreement with Orange
|
18
|
108
|
|||||||||||
Deferred revenues from HOT mobile
|
9,22
|
31
|
31
|
9
|
|||||||||
Other deferred revenues
|
22
|
38
|
41
|
12
|
|||||||||
Provisions
|
14
|
77
|
75
|
22
|
|||||||||
1,607
|
1,811
|
522
|
|||||||||||
NON CURRENT LIABILITIES
|
|||||||||||||
Notes payable
|
6,15
|
646
|
975
|
281
|
|||||||||
Borrowings from banks and others
|
6,15
|
1,550
|
243
|
69
|
|||||||||
Liability for employee rights upon retirement, net
|
16
|
39
|
40
|
12
|
|||||||||
Dismantling and restoring sites obligation
|
14
|
35
|
27
|
9
|
|||||||||
Deferred revenues from HOT mobile
|
9,22
|
195
|
164
|
47
|
|||||||||
Other non-current liabilities
|
14,22
|
14
|
24
|
7
|
|||||||||
2,479
|
1,473
|
425
|
|||||||||||
TOTAL LIABILITIES
|
4,086
|
3,284
|
947
|
||||||||||
EQUITY
|
21
|
||||||||||||
Share capital – ordinary shares of NIS 0.01 par value:
|
|||||||||||||
authorized – December 31, 2016 and 2017 – 235,000,000
|
|||||||||||||
shares; issued and outstanding -
|
2
|
2
|
1
|
||||||||||
December 31, 2016 – *156,993,337 shares
|
|||||||||||||
December 31, 2017 – *168,243,913 shares
|
|||||||||||||
Capital surplus
|
1,034
|
1,164
|
336
|
||||||||||
Accumulated retained earnings
|
358
|
491
|
142
|
||||||||||
Treasury shares, at cost –
|
|||||||||||||
December 31, 2016 – **3,603,578 shares
|
|||||||||||||
December 31, 2017 – **2,850,472 shares
|
(283
|
)
|
(223
|
)
|
(65
|
)
|
|||||||
TOTAL EQUITY
|
1,111
|
1,434
|
414
|
||||||||||
TOTAL LIABILITIES AND EQUITY
|
5,197
|
4,718
|
1,361
|
*
|
Net of treasury shares.
|
**
|
Including shares held by trustee under the Company’s Equity Incentive Plan, see note 21(a), such shares will become outstanding upon completion of vesting conditions, see note 21(b)
|
***
|
See Note 2(n) regarding the early adoption of IFRS 15, Revenue from Contracts with Customers.
|
Convenience
|
|||||||||||||||||
translation
|
|||||||||||||||||
into U.S. dollars
|
|||||||||||||||||
New Israeli Shekels
|
(note 2b3)
|
||||||||||||||||
Year ended December 31
|
|||||||||||||||||
2015
|
2016
|
2017*
|
2017*
|
||||||||||||||
Note
|
In millions (except earnings per share)
|
||||||||||||||||
Revenues, net
|
5, 22
|
4,111
|
3,544
|
3,268
|
943
|
||||||||||||
Cost of revenues
|
5, 22
|
3,472
|
2,924
|
2,627
|
758
|
||||||||||||
Gross profit
|
639
|
620
|
641
|
185
|
|||||||||||||
Selling and marketing expenses
|
22
|
417
|
426
|
269
|
78
|
||||||||||||
General and administrative expenses
|
22
|
223
|
263
|
196
|
56
|
||||||||||||
Income with respect to settlement
|
|||||||||||||||||
agreement with Orange
|
18
|
61
|
217
|
108
|
31
|
||||||||||||
Other income, net
|
23
|
47
|
45
|
31
|
9
|
||||||||||||
Operating profit
|
107
|
193
|
315
|
91
|
|||||||||||||
Finance income
|
24
|
13
|
13
|
4
|
1
|
||||||||||||
Finance expenses
|
24
|
156
|
118
|
184
|
53
|
||||||||||||
Finance costs, net
|
24
|
143
|
105
|
180
|
52
|
||||||||||||
Profit (loss) before income tax
|
(36
|
)
|
88
|
135
|
39
|
||||||||||||
Income tax expenses
|
25
|
4
|
36
|
21
|
6
|
||||||||||||
Profit (loss) for the year
|
(40
|
)
|
52
|
114
|
33
|
||||||||||||
Earnings (loss) per share
|
|||||||||||||||||
Basic
|
27
|
(0.26
|
)
|
0.33
|
0.70
|
0.20
|
|||||||||||
Diluted
|
27
|
(0.26
|
)
|
0.33
|
0.69
|
0.20
|
New Israeli Shekels
|
Convenience translation into U.S. dollars
(note 2b3)
|
||||||||||||||||
Year ended December 31
|
|||||||||||||||||
2015
|
2016
|
2017**
|
2017**
|
||||||||||||||
Note
|
In millions
|
||||||||||||||||
Profit (loss) for the year
|
(40
|
)
|
52
|
114
|
33
|
||||||||||||
Other comprehensive income (loss), items
|
|||||||||||||||||
that will not be reclassified to profit or loss
|
|||||||||||||||||
Remeasurements of post-employment benefit obligations
|
16
|
5
|
(8
|
)
|
(2
|
)
|
*
|
||||||||||
Income taxes relating to remeasurements of
|
|||||||||||||||||
post-employment benefit obligations
|
25
|
(1
|
)
|
2
|
1
|
*
|
|||||||||||
Other comprehensive income (loss)
|
|||||||||||||||||
for the year, net of income taxes
|
4
|
(6
|
)
|
(1
|
)
|
*
|
|||||||||||
TOTAL COMPREHENSIVE INCOME
|
|||||||||||||||||
(LOSS) FOR THE YEAR
|
(36
|
)
|
46
|
113
|
33
|
Share capital
|
||||||||||||||||||||||||
Number of
|
Capital
|
Accumulated
|
Treasury
|
|||||||||||||||||||||
Shares**
|
Amount
|
surplus
|
earnings
|
shares
|
Total
|
|||||||||||||||||||
I n m i l l i o n s
|
||||||||||||||||||||||||
New Israeli Shekels:
|
||||||||||||||||||||||||
BALANCE AT JANUARY 1, 2015
|
156,072,945
|
2
|
1,102
|
286
|
(351
|
)
|
1,039
|
|||||||||||||||||
CHANGES DURING THE YEAR ENDED DECEMBER 31, 2015
|
||||||||||||||||||||||||
Total comprehensive loss for the year
|
(36
|
)
|
(36
|
)
|
||||||||||||||||||||
Exercise of options and vesting of
restricted shares granted to employees
|
14,511
|
*
|
*
|
*
|
*
|
|||||||||||||||||||
Employee share-based compensation expenses
|
17
|
17
|
||||||||||||||||||||||
BALANCE AT DECEMBER 31, 2015
|
156,087,456
|
2
|
1,102
|
267
|
(351
|
)
|
1,020
|
|||||||||||||||||
CHANGES DURING THE YEAR ENDED DECEMBER 31, 2016
|
||||||||||||||||||||||||
Total comprehensive income for the year
|
46
|
46
|
||||||||||||||||||||||
Exercise of options and vesting of
restricted shares granted to employees
|
905,881
|
*
|
(68
|
)
|
68
|
*
|
||||||||||||||||||
Employee share-based compensation expenses
|
45
|
45
|
||||||||||||||||||||||
BALANCE AT DECEMBER 31, 2016
|
156,993,337
|
2
|
1,034
|
358
|
(283
|
)
|
1,111
|
|||||||||||||||||
CHANGES DURING THE YEAR ENDED DECEMBER 31, 2017
|
||||||||||||||||||||||||
Total comprehensive income for the year
|
113
|
113
|
||||||||||||||||||||||
Issuance of shares to shareholders (see note 21)
|
10,178,211
|
*
|
190
|
***
|
190
|
|||||||||||||||||||
Exercise of options and vesting of
restricted shares granted to employees
|
1,072,365
|
(60
|
)
|
60
|
||||||||||||||||||||
Employee share-based compensation expenses
|
*
|
20
|
20
|
|||||||||||||||||||||
BALANCE AT DECEMBER 31, 2017
|
168,243,913
|
2
|
1,164
|
491
|
(223
|
)
|
1,434
|
|||||||||||||||||
Convenience translation into U.S. Dollars (note 2b3):
|
||||||||||||||||||||||||
BALANCE AT JANUARY 1, 2017
|
156,993,337
|
1
|
298
|
103
|
(82
|
)
|
320
|
|||||||||||||||||
CHANGES DURING THE YEAR ENDED DECEMBER 31, 2017
|
||||||||||||||||||||||||
Total comprehensive income for the year
|
33
|
33
|
||||||||||||||||||||||
Issuance of shares to shareholders (see note 21)
|
10,178,211
|
*
|
55
|
***
|
55
|
|||||||||||||||||||
Exercise of options and vesting of
restricted shares granted to employees
|
1,072,365
|
(17
|
)
|
17
|
||||||||||||||||||||
Employee share-based compensation expenses
|
6
|
6
|
||||||||||||||||||||||
BALANCE AT DECEMBER 31, 2017
|
168,243,913
|
1
|
336
|
142
|
(65
|
)
|
414
|
New Israeli Shekels
|
Convenience translation into U.S. dollars
(note 2b3)
|
||||||||||||||||
Year ended December 31
|
|||||||||||||||||
2015
|
2016
|
2017**
|
2017**
|
||||||||||||||
Note
|
In millions
|
||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|||||||||||||||||
Cash generated from operations (Appendix)
|
955
|
975
|
1,002
|
288
|
|||||||||||||
Income tax paid
|
(33
|
)
|
(30
|
)
|
(29
|
)
|
(8
|
)
|
|||||||||
Net cash provided by operating activities
|
922
|
945
|
973
|
280
|
|||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|||||||||||||||||
Acquisition of property and equipment
|
(216
|
)
|
(127
|
)
|
(223
|
)
|
(64
|
)
|
|||||||||
Acquisition of intangible and other assets
|
(143
|
)
|
(69
|
)
|
(153
|
)
|
(44
|
)
|
|||||||||
Proceeds from (investment in) short-term deposits, net
|
(452
|
)
|
302
|
87
|
|||||||||||||
Interest received
|
24
|
3
|
2
|
2
|
1
|
||||||||||||
Proceeds from sale of property and equipment
|
23
|
1
|
7
|
*
|
*
|
||||||||||||
Investment in PHI
|
9
|
(1
|
)
|
||||||||||||||
Net cash used in investing activities
|
(356
|
)
|
(639
|
)
|
(72
|
)
|
(20
|
)
|
|||||||||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|||||||||||||||||
Share issuance
|
21
|
190
|
55
|
||||||||||||||
Proceeds from issuance of notes payable, net of issuance costs
|
15
|
650
|
187
|
||||||||||||||
Interest paid
|
(137
|
)
|
(108
|
)
|
(165
|
)
|
(48
|
)
|
|||||||||
Non-current borrowings received
|
6,15
|
675
|
250
|
350
|
101
|
||||||||||||
Repayment of non-current borrowings
|
15
|
(533
|
)
|
(15
|
)
|
(1,332
|
)
|
(384
|
)
|
||||||||
Repayment of notes payable
|
15
|
(308
|
)
|
(643
|
)
|
(443
|
)
|
(128
|
)
|
||||||||
Net cash used in financing activities
|
(303
|
)
|
(516
|
)
|
(750
|
)
|
(217
|
)
|
|||||||||
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
263
|
(210
|
)
|
151
|
43
|
||||||||||||
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR
|
663
|
926
|
716
|
207
|
|||||||||||||
CASH AND CASH EQUIVALENTS AT END OF YEAR
|
926
|
716
|
867
|
250
|
New Israeli Shekels |
Convenience translation into
U.S. dollars (note 2b3)
|
||||||||||||||||
Year ended December 31,
|
|||||||||||||||||
2015
|
2016
|
2017**
|
2017**
|
||||||||||||||
Note
|
In millions
|
||||||||||||||||
Cash generated from operations:
|
|||||||||||||||||
Profit (loss) for the year
|
(40
|
)
|
52
|
114
|
33
|
||||||||||||
Adjustments for:
|
|||||||||||||||||
Depreciation and amortization (including impairment)
|
10, 11, 13
|
641
|
565
|
540
|
156
|
||||||||||||
Amortization (including impairment) of deferred
|
|||||||||||||||||
expenses - Right of use
|
12, 13
|
112
|
30
|
40
|
12
|
||||||||||||
Employee share based compensation expenses
|
21
|
17
|
45
|
20
|
6
|
||||||||||||
Liability for employee rights upon retirement, net
|
16
|
(12
|
)
|
(3
|
)
|
(1
|
)
|
*
|
|||||||||
Finance costs, net
|
24
|
(8
|
)
|
1
|
(2
|
)
|
(1
|
)
|
|||||||||
Change in fair value of derivative financial instruments
|
6
|
(2
|
)
|
*
|
*
|
*
|
|||||||||||
Interest paid
|
24
|
137
|
108
|
165
|
47
|
||||||||||||
Interest received
|
24
|
(3
|
)
|
(2
|
)
|
(2
|
)
|
(1
|
)
|
||||||||
Deferred income taxes
|
25
|
(40
|
)
|
10
|
(13
|
)
|
(4
|
)
|
|||||||||
Income tax paid
|
25
|
33
|
30
|
29
|
8
|
||||||||||||
Changes in operating assets and liabilities:
|
|||||||||||||||||
Decrease (increase) in accounts receivable:
|
|||||||||||||||||
Trade
|
7
|
(183
|
)
|
226
|
283
|
82
|
|||||||||||
Other
|
(13
|
)
|
(9
|
)
|
6
|
2
|
|||||||||||
Increase (decrease) in accounts payable and accruals:
|
|||||||||||||||||
Trade
|
(5
|
)
|
(38
|
)
|
69
|
20
|
|||||||||||
Other payables
|
(12
|
)
|
*
|
(3
|
)
|
(1
|
)
|
||||||||||
Provisions
|
14
|
19
|
*
|
(2
|
)
|
(1
|
)
|
||||||||||
Deferred income with respect to settlement
|
|||||||||||||||||
agreement with Orange
|
18
|
325
|
(217
|
)
|
(108
|
)
|
(31
|
)
|
|||||||||
Deferred revenues from HOT mobile
|
9
|
227
|
(31
|
)
|
(9
|
)
|
|||||||||||
Other deferred revenues
|
(6
|
)
|
10
|
3
|
1
|
||||||||||||
Increase in deferred expenses - Right of use
|
12
|
(34
|
)
|
(80
|
)
|
(113
|
)
|
(33
|
)
|
||||||||
Current income tax
|
25
|
11
|
(4
|
)
|
5
|
1
|
|||||||||||
Decrease in inventories
|
8
|
18
|
24
|
3
|
1
|
||||||||||||
Cash generated from operations:
|
955
|
975
|
1,002
|
288
|
a. |
Reporting entity
|
b. |
Operating segments
|
(1) |
Cellular segment:
|
b. |
Operating segments (continued)
|
(2) |
Fixed-line segment
|
c. |
Main recent regulatory developments
|
(1) |
As part of the Economic Program Law for the years 2017-2018, that was published at the end of December 2016 it was determined, among others, that Bezeq and HOT Telecom will be required to allow other domestic operators including Partner, access to passive infrastructures. Following the enactment of this legislation, Bezeq has begun to partially observe its duty to provide access to its passive infrastructures and deployed several fiber optic cables for licensees using its own personnel.
|
(2) |
See information in respect of frequency fees in note 17(1).
|
(3) |
See information in respect of corporate tax rates in note 25.
|
d. |
Group licenses
|
Type of services
|
Area of service
|
License owner
|
Granted by
|
Valid through
|
Guarantees made
(NIS millions) |
|
(1)
|
Cellular
|
Israel
|
Partner Communications Company Ltd.
|
MOC
|
Feb, 2022
|
80
|
(2)
|
Cellular
|
West Bank
|
Partner Communications Company Ltd.
|
CA
|
Feb, 2022
|
4
|
(3)
|
ISP
|
Israel
|
Partner Communications Company Ltd.
|
MOC
|
Mar, 2023
|
|
(4)
|
ISP
|
West Bank
|
Partner Communications Company Ltd.
|
CA
|
Mar, 2023
|
|
(5)
|
ISP
|
Israel
|
012 Smile Telecom Ltd.
|
MOC
|
Jun, 2020
|
|
(6)
|
ISP
|
West Bank
|
012 Smile Telecom Ltd.
|
CA
|
Jun, 2020
|
|
(7)
|
ILD(*)
|
Israel
|
012 Smile Telecom Ltd.
|
MOC
|
Dec, 2029
|
5
|
(8)
|
ILD(**)
|
West Bank
|
012 Smile Telecom Ltd.
|
CA
|
Dec, 2029
|
0.25
|
(9)
|
Fixed(*)
|
Israel
|
012 Telecom Ltd.
|
MOC
|
Dec, 2025
|
5
|
(10)
|
Fixed(**)
|
West Bank
|
012 Telecom Ltd.
|
CA
|
Dec, 2025
|
0.25
|
(11)
|
Fixed(*)
(incl. ISP, ILD, NTP) |
Israel
|
Partner Land-line Communication Solutions - Limited Partnership
|
MOC
|
Jan, 2027
|
5
|
(12)
|
Fixed(**)
(incl. ISP, ILD, NTP) |
West Bank
|
Partner Land-line Communication Solutions - Limited Partnership
|
CA
|
Jan, 2027
|
0.25
|
(13)
|
NTP
|
Israel
|
012 Smile Telecom Ltd.
|
MOC
|
Dec, 2020
|
(*)
|
In February 2016, these licenses were replaced by the MoC with a general-unified license. The term of the new license is similar to the term of the previous license.
|
(**)
|
In July 2016, these licenses were replaced with a general-unified license. The general conditions of the general-unified license granted by the MoC, generally apply to these licenses, subject to certain modifications.
|
a. |
Basis of preparation of the financial statements
|
(1) |
Basis of preparation
|
(2) |
Use of estimates and judgments
|
b. |
Foreign currency translations
|
(1) |
Functional and presentation currency
|
(2) |
Transactions and balances
|
(3) |
Convenience translation into U.S. Dollars (USD or $ or dollar)
|
c. |
Interests in other entities
|
(1) |
Subsidiaries
|
c. |
Interests in other entities (continued)
|
(2) |
Investment in PHI
|
d. |
Inventories
|
e. |
Property and equipment
|
e. |
Property and equipment (continued)
|
years
|
|
Communications network:
|
|
Physical layer and infrastructure
|
10 - 25 (mainly 15, 10)
|
Other Communication network
|
3 - 15 (mainly 5, 10, 15)
|
Computers, software and hardware for information systems
|
3-10 (mainly 3-5)
|
Office furniture and equipment
|
7-15
|
Optic fibers and related assets
|
7-25 (mainly 20)
|
Subscribers equipment and installations
|
2 - 4
|
Property
|
25
|
f. |
Licenses and other intangible assets
|
(1) |
Licenses costs and amortization (see also note 1(d)):
|
(a) |
The licenses to operate cellular communication services were recognized at cost. Borrowing costs which served to finance the license fee - incurred until the commencement of utilization of the license - were capitalized to cost of the license.
|
(b) |
Partner Land-line Communication solutions – limited partnership’s license for providing fixed-line communication services is stated at cost.
|
(c) |
012 Smile and its subsidiaries’ licenses were recognized at fair value in a business combination as of the acquisition date of 012 Smile March 3, 2011.
|
f. |
Licenses and other intangible assets (continued)
|
(2) |
Computer software:
|
(3) |
Customer relationships:
|
(4) |
012 Smile trade name:
|
(5) |
Capitalization of contract costs according to IFRS15 (see note 2(n)):
|
g. |
Right Of Use (ROU)
|
h. |
Goodwill
|
i. |
Impairment of non-financial assets with finite useful economic lives
|
j. |
Financial instruments
|
j. |
Financial instruments (continued)
|
(1) |
Financial instruments at fair value through profit or loss category:
|
(2) |
Loans and receivables category:
|
(3) |
Financial liabilities and borrowings at amortized cost category:
|
k. |
Employee benefits
|
(i) |
Post-employment benefits
|
1. |
Defined contribution plan
|
2. |
Defined benefit plan
|
k. |
Employee benefits (continued)
|
(ii) |
Termination benefits
|
(iii) |
Short term employee benefits
|
1. |
Vacation and recreation benefits
|
2. |
Profit-sharing and bonus plans
|
3. |
Other short term benefits
|
l. |
Share based payments
|
m. |
Provisions
|
(1) |
In the ordinary course of business, the Group is involved in a number of lawsuits and litigations. The costs that may result from these lawsuits are only accrued for when it is probable that a liability, resulting from past events, will be incurred and the amount of that liability can be quantified or estimated within a reasonable range. The amount of the provisions recorded is based on a case-by-case assessment of the risk level, and events arising during the course of legal proceedings that may require a reassessment of this risk, and where applicable discounted at a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the liability. The Group’s assessment of risk is based both on the advice of legal counsel and on the Group’s estimate of the probable settlements amount that are expected to be incurred, if any. See also note 20.
|
(2) |
The Company is required to incur certain costs in respect of a liability to dismantle and remove assets and to restore sites on which the assets were located. The dismantling costs are calculated according to best estimate of future expected payments discounted at a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the liability. The increase in the provision due to the passage of time is recognized as finance costs.
|
(3) |
Provisions for equipment warranties include obligations to customers in respect of equipment sold. Where there are a number of similar obligations, the likelihood that an outflow will be required in a settlement is determined by considering the class of obligations as a whole. A provision is recognized even if the likelihood of an outflow with respect to any item included in the same class of obligations may be small.
|
(4) |
Group’s share in provisions recognized by PHI is recognized to the extent probable that the Group will be required to cover, see also note 9.
|
n. |
Revenues
|
1) |
Identifying the contract with the customer.
|
2) |
Identifying separate performance obligations in the contract.
|
3) |
Determining the transaction price.
|
4) |
Allocating the transaction price to separate performance obligations.
|
5) |
Recognizing revenue when the performance obligations are satisfied.
|
n. |
Revenues (continued)
|
n. |
Revenues (continued)
|
n. |
Revenues (continued)
|
New Israeli Shekels in millions
|
|||||||||||||
As of December 31, 2017
|
|||||||||||||
note
|
Previous accounting policy
|
Effect of change
|
According to IFRS15 as reported
|
||||||||||
Current assets - other receivables and prepaid expenses - Contract assets
|
-
|
2
|
2
|
||||||||||
Non-current assets - Costs to obtain contracts recognized in intangible assets, net – non-current assets
|
11, 2(f)(5)
|
-
|
71
|
71
|
|||||||||
Deferred income tax asset
|
25
|
71
|
(16
|
)
|
55
|
||||||||
Current liabilities - other deferred revenues – Contract liabilities
|
22
|
36
|
4
|
40
|
|||||||||
Non-current liabilities – other non-current liabilities – Contract liabilities
|
22
|
6
|
-
|
6
|
|||||||||
Deferred revenues from Hot Mobile – Contract liabilities (current and non-current)
|
22
|
195
|
-
|
195
|
|||||||||
Equity
|
1,381
|
53
|
1,434
|
New Israeli Shekels
In millions (except per share data) |
||||||||||||
Year ended December 31, 2017
|
||||||||||||
Previous
accounting policy
|
Effect of change
|
According to IFRS15 as reported
|
||||||||||
Revenues
|
3,270
|
(2
|
)
|
3,268
|
||||||||
Selling and marketing expenses
|
340
|
(71
|
)
|
269
|
||||||||
Operating profit
|
246
|
69
|
315
|
|||||||||
Profit before income tax
|
66
|
69
|
135
|
|||||||||
Income tax expenses
|
5
|
16
|
21
|
|||||||||
Profit for the year
|
61
|
53
|
114
|
|||||||||
Depreciation and amortization expense
|
567
|
13
|
580
|
|||||||||
Basic earnings per share
|
0.38
|
0.32
|
0.70
|
|||||||||
Diluted earnings per share
|
0.37
|
0.32
|
0.69
|
New Israeli Shekels in millions
|
||||||||||||
Year ended December 31, 2017
|
||||||||||||
Previous accounting policy
|
Effect of change
|
According to IFRS15 as reported
|
||||||||||
Net cash provided by operating activities
|
897
|
76
|
973
|
|||||||||
Net cash provided by (used in) investing activities
|
4
|
(76
|
)
|
(72
|
)
|
o. |
Leases
|
p. |
Tax expenses
|
q. |
Share capital
|
r. |
Earnings Per Share (EPS)
|
a. |
Critical accounting estimates and assumptions
|
(1) |
Assessing the useful lives of assets:
|
a. |
Critical accounting estimates and assumptions (continued)
|
(2) |
Assessing the recoverable amount for impairment tests of assets with finite useful lives:
|
a. |
Critical accounting estimates and assumptions (continued)
|
(3) |
Assessing the recoverable amount of goodwill for impairment tests:
|
Terminal growth rate
|
0.9
|
%
|
||
After-tax discount rate
|
9.3
|
%
|
||
Pre-tax discount rate
|
11.2
|
%
|
a. |
Critical accounting estimates and assumptions (continued)
|
(4) |
Assessing allowance for doubtful accounts:
|
(5) |
Considering uncertain tax positions:
|
b. |
Critical judgments in applying the Group’s accounting policies
|
(1) |
Considering the likelihood of contingent losses and quantifying possible settlements:
|
(2) |
Considering contracts with customers with multiple performance obligations:
|
(3) |
Accounting treatment for the investment in PHI:
|
New Israeli Shekels
|
||||||||||||||||
Year ended December 31, 2017*
|
||||||||||||||||
In millions
|
||||||||||||||||
Cellular segment
|
Fixed-line segment
|
Elimination
|
Consolidated
|
|||||||||||||
Segment revenue - Services
|
1,960
|
622
|
2,582
|
|||||||||||||
Inter-segment revenue - Services
|
18
|
155
|
(173
|
)
|
||||||||||||
Segment revenue - Equipment
|
610
|
76
|
686
|
|||||||||||||
Total revenues
|
2,588
|
853
|
(173
|
)
|
3,268
|
|||||||||||
Segment cost of revenues - Services
|
1,470
|
613
|
2,083
|
|||||||||||||
Inter-segment cost of revenues- Services
|
154
|
19
|
(173
|
)
|
||||||||||||
Segment cost of revenues - Equipment
|
490
|
54
|
544
|
|||||||||||||
Cost of revenues
|
2,114
|
686
|
(173
|
)
|
2,627
|
|||||||||||
Gross profit
|
474
|
167
|
641
|
|||||||||||||
Operating expenses (3)
|
367
|
98
|
465
|
|||||||||||||
Income with respect to settlement agreement with Orange
|
108
|
108
|
||||||||||||||
Other income, net
|
29
|
2
|
31
|
|||||||||||||
Operating profit
|
244
|
71
|
315
|
|||||||||||||
Adjustments to presentation of segment
|
||||||||||||||||
Adjusted EBITDA
|
||||||||||||||||
–Depreciation and amortization
|
445
|
135
|
||||||||||||||
–Other (1)
|
21
|
1
|
||||||||||||||
Segment Adjusted EBITDA (2)
|
710
|
207
|
New Israeli Shekels
|
||||
Year ended December 31, 2017*
|
||||
In millions
|
||||
Reconciliation of segments subtotal Adjusted EBITDA to profit for the year
|
||||
Segments subtotal Adjusted EBITDA (2)
|
917
|
|||
Depreciation and amortization
|
(580
|
)
|
||
Finance costs, net
|
(180
|
)
|
||
Income tax expenses
|
(21
|
)
|
||
Other (1)
|
(22
|
)
|
||
Profit for the year
|
114
|
New Israeli Shekels
|
||||||||||||||||
Year ended December 31, 2016
|
||||||||||||||||
In millions
|
||||||||||||||||
Cellular segment
|
Fixed-line segment
|
Elimination
|
Consolidated
|
|||||||||||||
Segment revenue - Services
|
2,080
|
672
|
2,752
|
|||||||||||||
Inter-segment revenue - Services
|
19
|
194
|
(213
|
)
|
||||||||||||
Segment revenue - Equipment
|
729
|
63
|
792
|
|||||||||||||
Total revenues
|
2,828
|
929
|
(213
|
)
|
3,544
|
|||||||||||
Segment cost of revenues - Services
|
1,659
|
617
|
2,276
|
|||||||||||||
Inter-segment cost of revenues- Services
|
192
|
21
|
(213
|
)
|
||||||||||||
Segment cost of revenues - Equipment
|
596
|
52
|
648
|
|||||||||||||
Cost of revenues
|
2,447
|
690
|
(213
|
)
|
2,924
|
|||||||||||
Gross profit
|
381
|
239
|
620
|
|||||||||||||
Operating expenses (3)
|
571
|
118
|
689
|
|||||||||||||
Income with respect to settlement agreement with Orange
|
217
|
217
|
||||||||||||||
Other income, net
|
41
|
4
|
45
|
|||||||||||||
Operating profit
|
68
|
125
|
193
|
|||||||||||||
Adjustments to presentation of segment
|
||||||||||||||||
Adjusted EBITDA
|
||||||||||||||||
–Depreciation and amortization
|
447
|
148
|
||||||||||||||
–Other (1)
|
47
|
(1
|
)
|
|||||||||||||
Segment Adjusted EBITDA (2)
|
562
|
272
|
New Israeli Shekels
|
||||
Year ended December 31, 2016
|
||||
In millions
|
||||
Reconciliation of segments subtotal Adjusted EBITDA to profit for the year
|
||||
Segments subtotal Adjusted EBITDA (2)
|
834
|
|||
Depreciation and amortization
|
(595
|
)
|
||
Other (1)
|
(46
|
)
|
||
Finance costs, net
|
(105
|
)
|
||
Income tax expenses
|
(36
|
)
|
||
Profit for the year
|
52
|
New Israeli Shekels
|
||||||||||||||||
Year ended December 31, 2015
|
||||||||||||||||
In millions
|
||||||||||||||||
Cellular segment
|
Fixed-line segment
|
Elimination
|
Consolidated
|
|||||||||||||
Segment revenue - Services
|
2,275
|
717
|
2,992
|
|||||||||||||
Inter-segment revenue - Services
|
22
|
189
|
(211
|
)
|
||||||||||||
Segment revenue - Equipment
|
1,051
|
68
|
1,119
|
|||||||||||||
Total revenues
|
3,348
|
974
|
(211
|
)
|
4,111
|
|||||||||||
Segment cost of revenues - Services
|
1,856
|
736
|
(*)
|
2,592
|
||||||||||||
Inter-segment cost of revenues- Services
|
187
|
24
|
(211
|
)
|
||||||||||||
Segment cost of revenues - Equipment
|
832
|
48
|
880
|
|||||||||||||
Cost of revenues
|
2,875
|
808
|
(211
|
)
|
3,472
|
|||||||||||
Gross profit
|
473
|
166
|
639
|
|||||||||||||
Operating expenses (3)
|
506
|
134
|
(*)
|
640
|
||||||||||||
Income with respect to settlement agreement with Orange
|
61
|
61
|
||||||||||||||
Other income, net
|
44
|
3
|
47
|
|||||||||||||
Operating profit
|
72
|
35
|
107
|
|||||||||||||
Adjustments to presentation of segment
|
||||||||||||||||
Adjusted EBITDA
|
||||||||||||||||
–Depreciation and amortization
|
||||||||||||||||
(including impairment charges, see note 13)
|
510
|
243
|
||||||||||||||
–Other (1)
|
15
|
1
|
||||||||||||||
Segment Adjusted EBITDA (2)
|
597
|
279
|
New Israeli Shekels
|
||||
Year ended December 31, 2015
|
||||
In millions
|
||||
Reconciliation of segments subtotal Adjusted EBITDA to loss for the year
|
||||
Segments subtotal Adjusted EBITDA (2)
|
876
|
|||
Depreciation and amortization (including impairment charges, see note 13)
|
(753
|
)
|
||
Other (1)
|
(16
|
)
|
||
Finance costs, net
|
(143
|
)
|
||
Income tax expenses
|
(4
|
)
|
||
Loss for the year
|
(40
|
)
|
(1) |
Mainly amortization of employee share based compensation.
|
(2) |
Adjusted EBITDA as reviewed by the CODM represents Earnings Before Interest (finance costs, net), Taxes, Depreciation and Amortization (including amortization of intangible assets, deferred expenses-right of use and impairment charges) and Other expenses (mainly amortization of share based compensation). Adjusted EBITDA is not a financial measure under IFRS and may not be comparable to other similarly titled measures for other companies. Adjusted EBITDA may not be indicative of the Group’s historic operating results nor is it meant to be predictive of potential future results. The usage of the term “Adjusted EBITDA” is to highlight the fact that the Amortization includes amortization of deferred expenses – right of use and amortization of employee share based compensation and impairment charges; it is fully comparable to EBITDA information which has been previously provided for prior periods.
|
(3) |
Operating expenses include selling and marketing expenses and general and administrative expenses.
|
a. |
Financial risk factors
|
1. |
Risk Management
|
2. |
Market risks
|
(a) |
Description of market risks
|
a. |
Financial risk factors (continued)
|
2. |
Market risks (continued)
|
(a) |
Description of market risks (continued)
|
Exchange
|
Exchange
|
|||||||||||
rate of one
|
rate of one
|
Israeli
|
||||||||||
Dollar
|
Euro
|
CPI*
|
||||||||||
At December 31:
|
||||||||||||
2017
|
NIS 3.467
|
NIS 4.153
|
221.57 points
|
|||||||||
2016
|
NIS 3.845
|
NIS 4.044
|
220.68 points
|
|||||||||
2015
|
NIS 3.902
|
NIS 4.247
|
221.13 points
|
|||||||||
Increase (decrease) during the year:
|
||||||||||||
2017
|
(9.8
|
)%
|
2.7
|
%
|
0.4
|
%
|
||||||
2016
|
(1.5
|
)%
|
(4.8
|
)%
|
(0.2
|
)%
|
||||||
2015
|
0.3
|
%
|
(10.1
|
)%
|
(1.0
|
)%
|
a. |
Financial risk factors (continued)
|
2. |
Market risks (continued)
|
(b) |
Analysis of linkage terms of financial instruments balances
|
December 31, 2017
|
||||||||||||||||||||
In or linked to USD
|
In or linked to other foreign currencies
(mainly EURO) |
NIS linked to CPI
|
NIS unlinked
|
Total
|
||||||||||||||||
New Israeli Shekels in millions
|
||||||||||||||||||||
Current assets
|
||||||||||||||||||||
Cash and cash equivalents
|
2
|
4
|
861
|
867
|
||||||||||||||||
Short term deposits
|
150
|
150
|
||||||||||||||||||
Trade receivables*
|
62
|
34
|
712
|
808
|
||||||||||||||||
Other receivables
|
9
|
9
|
||||||||||||||||||
Non- current assets
|
||||||||||||||||||||
Trade receivables
|
232
|
232
|
||||||||||||||||||
Total assets
|
64
|
38
|
1,964
|
2,066
|
||||||||||||||||
Current liabilities
|
||||||||||||||||||||
Current maturities of notes payable and borrowings
|
213
|
491
|
704
|
|||||||||||||||||
Trade payables*
|
143
|
32
|
612
|
787
|
||||||||||||||||
Payables in respect of employees
|
78
|
78
|
||||||||||||||||||
Other payables
|
21
|
21
|
||||||||||||||||||
Non- current liabilities
|
||||||||||||||||||||
Notes payable
|
972
|
972
|
||||||||||||||||||
Borrowings from banks and others
|
243
|
243
|
||||||||||||||||||
Total liabilities
|
143
|
32
|
213
|
2,417
|
2,805
|
In or linked to foreign currencies
|
||||
New Israeli Shekels in millions
|
||||
*Accounts that were set-off under enforceable netting arrangements
|
||||
Trade receivables gross amounts
|
281
|
|||
Set-off
|
(185
|
)
|
||
Trade receivables, net
|
96
|
|||
Trade payables gross amounts
|
360
|
|||
Set-off
|
(185
|
)
|
||
Trade payables, net
|
175
|
a. |
Financial risk factors (continued)
|
2. |
Market risks (continued)
|
(b) |
Analysis of linkage terms of financial instruments balances (continued)
|
December 31, 2016
|
||||||||||||||||||||
In or linked to USD
|
In or linked to other foreign currencies
(mainly EURO) |
NIS linked to CPI
|
NIS unlinked
|
Total
|
||||||||||||||||
New Israeli Shekels in millions
|
||||||||||||||||||||
Current assets
|
||||||||||||||||||||
Cash and cash equivalents
|
2
|
1
|
713
|
716
|
||||||||||||||||
Short term deposits
|
452
|
452
|
||||||||||||||||||
Trade receivables*
|
58
|
35
|
897
|
990
|
||||||||||||||||
Other receivables
|
39
|
39
|
||||||||||||||||||
Non- current assets
|
||||||||||||||||||||
Trade receivables
|
333
|
333
|
||||||||||||||||||
Total assets
|
60
|
36
|
2,434
|
2,530
|
||||||||||||||||
Current liabilities
|
||||||||||||||||||||
Current maturities of notes payable and borrowings
|
212
|
287
|
499
|
|||||||||||||||||
Trade payables*
|
132
|
19
|
530
|
681
|
||||||||||||||||
Payables in respect of employees
|
90
|
90
|
||||||||||||||||||
Other payables
|
10
|
10
|
||||||||||||||||||
Non- current liabilities
|
||||||||||||||||||||
Notes payable
|
212
|
437
|
649
|
|||||||||||||||||
Borrowings from banks and others
|
197
|
1,353
|
1,550
|
|||||||||||||||||
Total liabilities
|
132
|
19
|
621
|
2,707
|
3,479
|
In or linked to foreign currencies
|
||||
New Israeli Shekels in millions
|
||||
*Accounts that were set-off under enforceable netting arrangements
|
||||
Trade receivables gross amounts
|
267
|
|||
Set-off
|
(174
|
)
|
||
Trade receivables, net
|
93
|
|||
Trade payables gross amounts
|
325
|
|||
Set-off
|
(174
|
)
|
||
Trade payables, net
|
151
|
a. |
Financial risk factors (continued)
|
2. |
Market risks (continued)
|
(c) |
Details regarding the derivative financial instruments
|
New Israeli Shekels
|
||||||||
December 31
|
||||||||
2016
|
2017
|
|||||||
In millions
|
||||||||
Embedded derivatives pay USD, receive NIS
|
11
|
3
|
a. |
Financial risk factors (continued)
|
3. |
Credit risk
|
a. |
Financial risk factors (continued)
|
4. |
Liquidity risk
|
2018
|
2019
|
2020
|
2021
to
2022
|
2023
to
2024
|
Total
|
|||||||||||||||||||
New Israeli Shekels in millions
|
||||||||||||||||||||||||
Principal payments of long term indebtedness:
|
||||||||||||||||||||||||
Notes payable series C (1)
|
213
|
213
|
||||||||||||||||||||||
Notes payable series D
|
109
|
109
|
109
|
110
|
437
|
|||||||||||||||||||
Notes payable series F
|
129
|
258
|
257
|
644
|
||||||||||||||||||||
Borrowing K (2)
|
75
|
75
|
||||||||||||||||||||||
Borrowing L (3)
|
200
|
200
|
||||||||||||||||||||||
Borrowing O (3)
|
100
|
100
|
||||||||||||||||||||||
Borrowing P
|
7
|
29
|
29
|
60
|
125
|
|||||||||||||||||||
Borrowing Q
|
23
|
23
|
45
|
34
|
125
|
|||||||||||||||||||
Expected interest payments of
|
||||||||||||||||||||||||
long term borrowings and notes payables (1) (2)
|
68
|
23
|
19
|
23
|
7
|
140
|
||||||||||||||||||
Trade and other payables
|
865
|
865
|
||||||||||||||||||||||
Total
|
1,637
|
184
|
309
|
496
|
298
|
2,924
|
||||||||||||||||||
Add offering expenses and discounts and premiums
|
4
|
|||||||||||||||||||||||
2,928
|
b. |
Capital risk management
|
c. |
Fair values of financial instruments
|
December 31, 2016
|
December 31, 2017
|
||||||||||||||||||||||||
Category
|
Carrying amount
|
Fair value
|
Interest rate used (**)
|
Carrying amount
|
Fair value
|
Interest rate used (**)
|
|||||||||||||||||||
New Israeli Shekels in millions
|
|||||||||||||||||||||||||
Assets
|
|||||||||||||||||||||||||
Cash and cash equivalents
|
L&R
|
716
|
716
|
867
|
867
|
||||||||||||||||||||
Short term deposits
|
L&R
|
452
|
452
|
150
|
150
|
||||||||||||||||||||
Trade receivables
|
L&R
|
1,323
|
1,318
|
4.72
|
%
|
1,040
|
1,040
|
4.47
|
%
|
||||||||||||||||
Other receivables (*)
|
L&R
|
9
|
9
|
9
|
9
|
||||||||||||||||||||
Liabilities
|
|||||||||||||||||||||||||
Notes payable series C
|
AC
|
423
|
440
|
Market quote
|
213
|
219
|
Market quote
|
||||||||||||||||||
Notes payable series D
|
AC
|
543
|
548
|
Market quote
|
435
|
443
|
Market quote
|
||||||||||||||||||
Notes payable series E
|
AC
|
121
|
127
|
Market quote
|
|||||||||||||||||||||
Notes payable series F
|
AC
|
650
|
659
|
Market quote
|
|||||||||||||||||||||
Trade and other payables (*)
|
AC
|
771
|
771
|
865
|
865
|
||||||||||||||||||||
Borrowing C
|
AC
|
75
|
81
|
3.43
|
%
|
||||||||||||||||||||
Borrowing D
|
AC
|
75
|
81
|
3.43
|
%
|
||||||||||||||||||||
Borrowing E (*)
|
AC
|
152
|
152
|
||||||||||||||||||||||
Borrowing F
|
AC
|
197
|
199
|
3.17
|
%
|
||||||||||||||||||||
Borrowing G
|
AC
|
100
|
98
|
3.85
|
%
|
||||||||||||||||||||
Borrowing H
|
AC
|
100
|
97
|
3.85
|
%
|
||||||||||||||||||||
Borrowing I
|
AC
|
120
|
120
|
3.43
|
%
|
||||||||||||||||||||
Borrowing J
|
AC
|
62
|
62
|
3.23
|
%
|
||||||||||||||||||||
Borrowing K
|
AC
|
76
|
76
|
3.43
|
%
|
75
|
75
|
3.71
|
%
|
||||||||||||||||
Borrowing L
|
AC
|
200
|
204
|
3.98
|
%
|
200
|
200
|
4.25
|
%
|
||||||||||||||||
Borrowing M
|
AC
|
200
|
201
|
3.85
|
%
|
||||||||||||||||||||
Borrowing N
|
AC
|
250
|
260
|
3.67
|
%
|
||||||||||||||||||||
Borrowing O
|
AC
|
100
|
110
|
4.34
|
%
|
||||||||||||||||||||
Borrowing P
|
AC
|
125
|
125
|
2.38
|
%
|
||||||||||||||||||||
Borrowing Q
|
AC
|
125
|
125
|
2.5
|
%
|
||||||||||||||||||||
Interest payable (*)
|
AC
|
9
|
9
|
21
|
21
|
||||||||||||||||||||
Derivative financial instruments
|
FVTPL
|
||||||||||||||||||||||||
Level 2
|
*
|
*
|
*
|
*
|
(*)
|
The fair value of these financial instruments equals their carrying amounts, as the impact of discounting is not significant.
|
(**) |
The fair values of the notes payable quoted market prices at the end of the reporting period are within level 1 of the fair value hierarchy. The fair values of other instruments under AC categories were calculated based on observable weighted average of interest rates derived from quoted market prices of the Group’s notes payable and bank quotes of rates of similar terms and nature, are within level 2 of the fair value hierarchy.
|
(a) |
Composition:
|
New Israeli Shekels
|
||||||||
December 31
|
||||||||
2016
|
2017
|
|||||||
In millions
|
||||||||
Trade (current and non-current)
|
1,545
|
1,260
|
||||||
Deferred interest income (note 2(n))
|
(32
|
)
|
(27
|
)
|
||||
Allowance for doubtful accounts
|
(190
|
)
|
(193
|
)
|
||||
1,323
|
1,040
|
|||||||
Current
|
990
|
808
|
||||||
Non – current
|
333
|
232
|
(b) |
Allowance for doubtful accounts:
|
New Israeli Shekels
|
||||||||||||
Year ended
|
||||||||||||
2015
|
2016
|
2017
|
||||||||||
In millions
|
||||||||||||
Balance at beginning of year
|
166
|
169
|
190
|
|||||||||
Receivables written-off during the year as uncollectible
|
(61
|
)
|
(61
|
)
|
(49
|
)
|
||||||
Charge or expense during the year
|
64
|
82
|
52
|
|||||||||
Balance at end of year
|
169
|
190
|
193
|
(b) |
Allowance for doubtful accounts (continued)
|
New Israeli Shekels
|
||||||||||||||||
December 31
|
||||||||||||||||
2016
|
2017
|
|||||||||||||||
In millions
|
||||||||||||||||
Gross
|
Allowance
|
Gross
|
Allowance
|
|||||||||||||
Less than one year
|
1,420
|
101
|
1,089
|
69
|
||||||||||||
More than one year
|
125
|
89
|
171
|
124
|
||||||||||||
1,545
|
190
|
1,260
|
193
|
New Israeli Shekels
|
||||||||
December 31
|
||||||||
2016
|
2017
|
|||||||
In millions
|
||||||||
Handsets and devices
|
60
|
60
|
||||||
Accessories and other
|
9
|
8
|
||||||
Spare parts
|
22
|
19
|
||||||
ISP modems, routers, servers and related equipment
|
5
|
6
|
||||||
96
|
93
|
|||||||
Write-offs recorded
|
6
|
5
|
||||||
Cost of inventory recognized as expenses and included in cost of revenues for the year ended
|
673
|
558
|
As at December 31
|
||||||||
2016
|
2017
|
|||||||
NIS in millions
|
NIS in millions
|
|||||||
Current assets
|
122
|
119
|
||||||
Non-current assets
|
115
|
218
|
||||||
Current liabilities
|
110
|
117
|
||||||
Non-current liabilities
|
125
|
218
|
||||||
Net assets
|
2
|
2
|
||||||
Supplemental information relating to associates:
|
||||||||
Commitments for operating leases and operating expenses
|
364
|
443
|
||||||
Commitments to purchase fixed assets
|
3
|
2
|
||||||
Guarantees made to third parties
|
1
|
Year ended December 31
|
||||||||
2016
|
2017
|
|||||||
NIS in millions
|
NIS in millions
|
|||||||
Summarized statement of income
|
||||||||
Revenue
|
432
|
477
|
||||||
Pre-tax Profit
|
*
|
-
|
||||||
After-tax profit
|
*
|
-
|
||||||
Total comprehensive income
|
*
|
-
|
||||||
Reconciliation to carrying amount:
|
||||||||
Opening net assets of PHI
|
2
|
2
|
||||||
Profit for the period
|
*
|
-
|
||||||
Closing net assets of PHI
|
2
|
2
|
||||||
Carrying amount: Group’s share (50%)
|
1
|
1
|
Communication network
|
Computers and information systems
|
Optic fibers and related assets
|
Subscribers equipment and installations(1)
|
Property, leasehold improvements, furniture and equipment
|
Total
|
|||||||||||||||||||
New Israeli Shekels in millions
|
||||||||||||||||||||||||
Cost
|
||||||||||||||||||||||||
Balance at January 1, 2015
|
2,504
|
303
|
469
|
-
|
229
|
3,505
|
||||||||||||||||||
Additions in 2015
|
106
|
(1)
|
*
|
19
|
12
|
4
|
141
|
|||||||||||||||||
Disposals in 2015
|
423
|
39
|
2
|
*
|
30
|
494
|
||||||||||||||||||
Balance at December 31, 2015
|
2,187
|
(1)
|
264
|
486
|
12
|
203
|
3,152
|
|||||||||||||||||
Additions in 2016
|
51
|
(1)
|
17
|
22
|
17
|
9
|
(1)
|
116
|
||||||||||||||||
Disposals in 2016
|
235
|
74
|
78
|
387
|
||||||||||||||||||||
Balance at December 31, 2016
|
2,003
|
(1)
|
207
|
508
|
29
|
134
|
(1)
|
2,881
|
||||||||||||||||
|
||||||||||||||||||||||||
Additions in 2017
|
55
|
7
|
97
|
109
|
6
|
274
|
||||||||||||||||||
Disposals in 2017
|
165
|
60
|
1
|
3
|
229
|
|||||||||||||||||||
Balance at December 31, 2017
|
1,893
|
154
|
604
|
138
|
137
|
2,926
|
||||||||||||||||||
|
||||||||||||||||||||||||
Accumulated depreciation
|
||||||||||||||||||||||||
Balance at January 1, 2015
|
1,379
|
178
|
151
|
-
|
136
|
1,844
|
||||||||||||||||||
Depreciation in 2015
|
270
|
(1)
|
45
|
34
|
1
|
26
|
376
|
|||||||||||||||||
Impairment charges (2)
|
5
|
7
|
12
|
|||||||||||||||||||||
Disposals in 2015
|
423
|
39
|
2
|
30
|
494
|
|||||||||||||||||||
Balance at December 31, 2015
|
1,231
|
(1)
|
191
|
183
|
1
|
132
|
1,738
|
|||||||||||||||||
|
||||||||||||||||||||||||
Depreciation in 2016
|
223
|
(1)
|
29
|
35
|
6
|
23
|
316
|
|||||||||||||||||
Disposals in 2016
|
230
|
74
|
76
|
380
|
||||||||||||||||||||
Balance at December 31, 2016
|
1,224
|
(1)
|
146
|
218
|
7
|
79
|
1,674
|
|||||||||||||||||
|
||||||||||||||||||||||||
Depreciation in 2017
|
204
|
22
|
36
|
24
|
15
|
301
|
||||||||||||||||||
Disposals in 2017
|
165
|
60
|
1
|
3
|
229
|
|||||||||||||||||||
Balance at December 31, 2017
|
1,263
|
108
|
253
|
31
|
91
|
1,746
|
||||||||||||||||||
|
||||||||||||||||||||||||
Carrying amounts, net
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
At December 31, 2015
|
956
|
(1)
|
73
|
303
|
11
|
71
|
1,414
|
|||||||||||||||||
At December 31, 2016
|
779
|
(1)
|
61
|
290
|
22
|
55
|
(1)
|
1,207
|
||||||||||||||||
At December 31, 2017
|
630
|
46
|
351
|
107
|
46
|
1,180
|
New Israeli Shekels
|
||||||||||||
Year ended December 31
|
||||||||||||
2015
|
2016
|
2017
|
||||||||||
In millions
|
||||||||||||
Cost additions include capitalization of salary and employee related expenses
|
30
|
29
|
33
|
Licenses
|
Costs of obtaining contracts with customers(4)
|
Trade name |
Customer relationships
|
Subscriber acquisition and retention costs
|
Computer
software(1)
|
Total
|
||||||||||||||||||||||
New Israeli Shekels in millions
|
||||||||||||||||||||||||||||
Cost
|
||||||||||||||||||||||||||||
At January 1, 2015
|
2,088
|
73
|
276
|
13
|
646
|
3,096
|
||||||||||||||||||||||
Additions in 2015
|
35
|
6
|
89
|
130
|
||||||||||||||||||||||||
Disposals in 2015
|
6
|
73
|
79
|
|||||||||||||||||||||||||
At December 31, 2015
|
2,123
|
73
|
276
|
13
|
662
|
3,147
|
||||||||||||||||||||||
Additions in 2016
|
4
|
82
|
86
|
|||||||||||||||||||||||||
Disposals in 2016
|
4
|
110
|
114
|
|||||||||||||||||||||||||
At December 31, 2016
|
2,123
|
73
|
276
|
13
|
634
|
3,119
|
||||||||||||||||||||||
Transition to IFRS 15(4)
|
2
|
(13
|
)
|
(11
|
)
|
|||||||||||||||||||||||
Additions in 2017
|
84
|
59
|
143
|
|||||||||||||||||||||||||
Disposals in 2017
|
73
|
128
|
201
|
|||||||||||||||||||||||||
At December 31, 2017
|
2,123
|
86
|
-
|
276
|
-
|
565
|
3,050
|
|||||||||||||||||||||
|
||||||||||||||||||||||||||||
Accumulated amortization
|
||||||||||||||||||||||||||||
At January 1, 2015
|
1,502
|
33
|
188
|
9
|
285
|
2,017
|
||||||||||||||||||||||
Amortization in 2015(2)
|
86
|
6
|
23
|
7
|
121
|
243
|
||||||||||||||||||||||
Impairment charges (3)
|
2
|
8
|
10
|
|||||||||||||||||||||||||
Disposals in 2015
|
6
|
73
|
79
|
|||||||||||||||||||||||||
At December 31, 2015
|
1,588
|
41
|
219
|
10
|
333
|
2,191
|
||||||||||||||||||||||
Amortization in 2016
|
88
|
21
|
18
|
5
|
117
|
249
|
||||||||||||||||||||||
Disposals in 2016
|
4
|
110
|
114
|
|||||||||||||||||||||||||
At December 31, 2016
|
1,676
|
62
|
237
|
11
|
340
|
2,326
|
||||||||||||||||||||||
Transition to IFRS 15(4)
|
(11
|
)
|
(11
|
)
|
||||||||||||||||||||||||
Amortization in 2017
|
88
|
15
|
11
|
18
|
107
|
239
|
||||||||||||||||||||||
Disposals in 2017
|
73
|
128
|
201
|
|||||||||||||||||||||||||
At December 31, 2017
|
1,764
|
15
|
-
|
255
|
-
|
319
|
2,353
|
|||||||||||||||||||||
|
||||||||||||||||||||||||||||
Carrying amounts, net
|
||||||||||||||||||||||||||||
At December 31, 2015
|
535
|
32
|
57
|
3
|
329
|
956
|
||||||||||||||||||||||
At December 31, 2016
|
447
|
11
|
39
|
2
|
294
|
793
|
||||||||||||||||||||||
At December 31, 2017
|
359
|
71
|
-
|
21
|
-
|
246
|
697
|
New Israeli Shekels
|
||||||||||||
Year ended December 31
|
||||||||||||
2015
|
2016
|
2017
|
||||||||||
In millions
|
||||||||||||
(1) Cost additions include capitalization of salary and employee related expenses
|
35
|
36
|
44
|
New Israeli Shekels in millions
|
||||
Cost
|
||||
Balance at January 1, 2015
|
402
|
|||
Additional payments in 2015
|
34
|
|||
Balance at December 31, 2015
|
436
|
|||
Additional payments in 2016
|
80
|
|||
Balance at December 31, 2016
|
516
|
|||
Additional payments in 2017
|
113
|
|||
Balance at December 31, 2017
|
629
|
|||
Accumulated amortization and impairment
|
||||
Balance at January 1, 2015
|
271
|
|||
Amortization in 2015
|
36
|
|||
Impairment recorded in 2015
|
76
|
|||
Balance at December 31, 2015
|
383
|
|||
Amortization in 2016
|
30
|
|||
Balance at December 31, 2016
|
413
|
|||
Amortization in 2017
|
40
|
|||
Balance at December 31, 2017
|
453
|
|||
Carrying amount, net at December 31, 2015
|
53
|
|||
Carrying amount, net at December 31, 2016
|
103
|
|||
Current
|
28
|
|||
Non-current
|
75
|
|||
Carrying amount, net at December 31, 2017
|
176
|
|||
Current
|
43
|
|||
Non-current
|
133
|
(1) |
Goodwill impairment tests
|
As of December 31,
|
||||||||||||
2015
|
2016
|
2017
|
||||||||||
Terminal growth rate
|
(negative 0.09%
|
) |
0.5
|
%
|
0.9
|
%
|
||||||
After-tax discount rate
|
10.3
|
%
|
9.8
|
%
|
9.3
|
%
|
||||||
Pre-tax discount rate
|
13.4
|
%
|
11.9
|
%
|
11.2
|
%
|
(2) |
Impairment tests of assets with finite useful lives
|
(i) |
The Group reviewed in 2015 the recoverability of the VOB/ISP CGU assets. As a result, an impairment charge in a total amount of NIS 98 million was recognized in 2015. The impairment charge was allocated to the assets of the CGU pro rata, on the basis of the carrying amount of each asset, provided that the impairment did not reduce the carrying amount of an asset below the highest of its fair value less costs to sell and its value-in-use, and zero. Accordingly, the following impairment charges were recorded in 2015 in the assets of the above CGU:
|
(a) |
Right of use by NIS 76 million, recorded in cost of revenues (see note 12).
|
(b) |
Customer relationships by NIS 8 million, recorded in selling and marketing expenses.
|
(c) |
Computers and information systems by NIS 7 million, recorded in cost of revenues.
|
(d) |
Communication network by NIS 5 million, recorded in cost of revenues.
|
(e) |
Trade name by NIS 2 million, recorded in selling and marketing expenses.
|
(2) |
Impairment tests of assets with finite useful lives (continued)
|
(ii) |
The Group reviewed the recoverability of the ILD CGU of the fixed line segment and determined that no impairment existed as of December 31, 2015.
|
Group’s share in PHI’s provisions
(see note 9) |
Dismantling and restoring sites obligation
|
Legal claims
(see note 20) |
Equipment warranty
|
|||||||||||||
New Israeli Shekels in millions
|
||||||||||||||||
Balance as at January 1, 2017
|
-
|
35
|
76
|
1
|
||||||||||||
Additions during the year
|
7
|
5
|
8
|
7
|
||||||||||||
Reductions during the year
|
(14
|
)
|
(12
|
)
|
(5
|
)
|
||||||||||
Finance costs
|
1
|
|||||||||||||||
Balance as at December 31, 2017
|
7
|
27
|
72
|
3
|
||||||||||||
Non-current
|
7
|
27
|
||||||||||||||
Current
|
72
|
3
|
||||||||||||||
Balance as at December 31, 2016
|
35
|
76
|
1
|
|||||||||||||
Non-current
|
35
|
|||||||||||||||
Current
|
76
|
1
|
(1) |
Borrowings and Notes Payable
|
Linkage terms (principal and interest)
|
Annual interest rate
|
|||
Notes payable series C
|
Note 15(4)
|
CPI
|
3.35% CPI adj.
|
|
Notes payable series D
|
‘Makam'(*) plus 1.2%
|
|||
Notes payable series F
|
Note 15(2), (6)
|
2.16% fixed
|
||
Borrowing K (received in 2015)
|
Note 15(5)
|
3.71% fixed
|
||
Borrowing L (received in 2015)
|
Note 15(5)
|
4.25% fixed
|
||
Borrowing O (received in 2017)
|
Note 15(3), (5)
|
4.34% fixed
|
||
Borrowing P (received in 2017)
|
Note 15(3)
|
2.38% fixed
|
||
Borrowing Q (received in 2017)
|
Note 15(3)
|
2.5% fixed
|
(1) |
Borrowings and Notes Payable (continued)
|
Movement in 2017
|
||||||||||||||||||||
As at December 31, 2016
|
Cash flows from (used in) financing activities, net
|
Non cash movements
|
As at December 31, 2017 |
|||||||||||||||||
CPI adjustments and other finance costs
|
Change in estimated cash flows(*)
|
|||||||||||||||||||
New Israeli Shekels in millions
|
||||||||||||||||||||
Non-current borrowings, including current maturities
|
1,607
|
(982
|
)
|
625
|
||||||||||||||||
Notes payable, including current maturities
|
1,087
|
207
|
4
|
1,298
|
||||||||||||||||
Interest payable
|
9
|
(165
|
)
|
159
|
18
|
21
|
||||||||||||||
2,703
|
(940
|
)
|
163
|
18
|
1,944
|
(2) |
Notes payable issuance
|
(3) |
New borrowings received
|
(4) |
Notes payable buy back
|
(5) |
Borrowings early repayments
|
(6) |
Notes payable issuance commitments
|
(7) |
Financial covenants
|
(a) |
Regarding Series F Notes and borrowings P and Q, the Company is required to comply with a financial covenant that the ratio of Net Debt to Adjusted EBITDA shall not exceed 5. Compliance will be examined and reported on a quarterly basis. For the purpose of the covenant, Adjusted EBITDA is calculated as the sum total for the last 12 month period, excluding adjustable one-time items. As of December 31, 2017, the ratio of Net Debt to Adjusted EBITDA was 1.0. Additional stipulations regarding Series F Notes and borrowings P and Q mainly include: shareholders' equity shall not decrease below NIS 400 million; the Company shall not create floating liens subject to certain terms; the Company has the right for early redemption under certain conditions; the Company shall pay additional annual interest of 0.5% in the case of a two-notch downgrade in the Series F Notes rating and an additional annual interest of 0.25% for each further single-notch downgrade, up to a maximum additional interest of 1%; the Company shall pay additional annual interest of 0.25% during a period in which there is a breach of the financial covenant. The Group was in compliance with the financial covenant and the additional stipulations for the year 2017.
|
(b) |
Regarding borrowings K, L and O, as of December 31, 2017 (see information about early repayments in note 15(5) above), the Company is required to comply with financial covenants on a consolidated basis. Their main provisions are two ratios:
|
(1) |
The ratio of (a) the amount of all financial obligations of the Company including bank guarantees that the Company has undertaken ("Total Debt") to (b) EBITDA less Capital Expenditures shall not exceed 6.5 (the ratio as of December 31, 2016 and 2017 was 4.5 and 4.1, respectively); and
|
(2) |
The ratio of (a) Total Debt to (b) the EBITDA of the Company shall not exceed 4 (the ratio as of December 31, 2016 and 2017 was 3.4 and 2.2, respectively).
|
(1) |
Defined contribution plan
|
(2) |
Defined benefit plan
|
New Israeli Shekels in millions
|
||||||||||||
Present value of obligation
|
Fair value of plan assets
|
Total
|
||||||||||
At January 1, 2016
|
133
|
(99
|
)
|
34
|
||||||||
Current service cost
|
17
|
17
|
||||||||||
Interest expense (income)
|
5
|
(3
|
)
|
2
|
||||||||
Employer contributions
|
(12
|
)
|
(12
|
)
|
||||||||
Benefits paid
|
(19
|
)
|
9
|
(10
|
)
|
|||||||
Remeasurements:
|
||||||||||||
Experience loss
|
9
|
9
|
||||||||||
Loss (gain) from change in demographic assumptions
|
(4
|
)
|
(4
|
)
|
||||||||
Loss from change in financial assumptions
|
1
|
1
|
||||||||||
Return on plan assets
|
2
|
2
|
||||||||||
At December 31, 2016
|
142
|
(103
|
)
|
39
|
||||||||
Current service cost
|
11
|
11
|
||||||||||
Past service cost
|
4
|
4
|
||||||||||
Interest expense (income)
|
4
|
(3
|
)
|
1
|
||||||||
Employer contributions
|
(9
|
)
|
(9
|
)
|
||||||||
Benefits paid
|
(25
|
)
|
17
|
(8
|
)
|
|||||||
Remeasurements:
|
||||||||||||
Experience loss
|
2
|
2
|
||||||||||
Loss (gain) from change in financial assumptions
|
1
|
1
|
||||||||||
Return on plan assets
|
(1
|
)
|
(1
|
)
|
||||||||
At December 31, 2017
|
139
|
(99
|
)
|
40
|
(2) |
Defined benefit plan (continued)
|
December 31
|
||||||||
2016
|
2017
|
|||||||
Interest rate weighted average
|
2.95
|
%
|
2.73
|
%
|
||||
Inflation rate weighted average
|
1.04
|
%
|
1.11
|
%
|
||||
Expected turnover rate
|
9%-56
|
%
|
9%-56
|
%
|
||||
Future salary increases
|
1%-6
|
%
|
1%-6
|
%
|
December 31, 2017
|
||||||||
NIS in millions
|
||||||||
Increase of 10% of the assumption
|
Decrease of 10% of the assumption
|
|||||||
Interest rate
|
(0.6
|
)
|
0.8
|
|||||
Expected turnover rate
|
0.2
|
(0.3
|
)
|
|||||
Future salary increases
|
0.4
|
(0.4
|
)
|
NIS in millions
|
||||
2018
|
24
|
|||
2019
|
20
|
|||
2020
|
11
|
|||
2021 and 2022
|
20
|
|||
2023 and thereafter
|
83
|
|||
158
|
(1) |
Under the Telegraph Regulations the Company is committed to pay an annual fixed fee for each frequency used. For the years 2015, 2016 and 2017 the Company recorded expenses in a total amount of approximately NIS 65 million, NIS 64 million and NIS 63 million, respectively. Under the above Regulations should the Company choose to return a frequency, such payment is no longer due. Commencing August 2016, the total amount of frequency fees of both the Company and Hot Mobile under the regulations are divided between the Company and Hot Mobile, through PHI ,according to the OPEX-CAPEX mechanism (see also note 9).
|
(2) |
At December 31, 2017, the Group is committed to acquire property and equipment and software elements for approximately NIS 5 million.
|
(3) |
At December 31, 2017, the Group is committed to acquire inventory in an amount of approximately NIS 818 million.
|
(4) |
Right of Use (ROU)
|
New Israeli
Shekels in millions
|
||||
2018
|
43
|
|||
2019
|
41
|
|||
2020
|
41
|
|||
2021
|
41
|
|||
2022
|
41
|
|||
207
|
(5) |
Liens and guarantees
|
(6) |
Covenants and negative pledge – see note 15(7).
|
(7) |
See note 15(6) with respect of notes payable issuance commitments.
|
(8) |
Operating leases – see note 19.
|
(9) |
See note 9 with respect to network sharing and PHI's commitments.
|
(1) |
The Group leases it's headquarter facilities in Rosh Ha-ayin, Israel, with a total of approximately 51,177 gross square meters (including parking lots). The lease term is until the end of 2024. The rental payments are linked to the Israeli CPI.
|
(2) |
The Group also leases call centers, retail stores and service centers. The leases for each site have different lengths and specific terms. The lease agreements are for periods of two to ten years. The Group has options to extend some lease contract periods for up to twenty years (including the original lease periods). Some of the rental payments are linked to the dollar or to the Israeli CPI. Some of the extension options include an increase of the lease payment in a range of 2%-15%.
|
(3) |
Lease agreements in respect of cell sites and switching stations throughout Israel are for periods of two to ten years. The Company has an option to extend some of the lease contract periods for up to ten years (including the original lease periods). Some of the rental payments fees are linked to the dollar or linked to the Israeli CPI. Some of the extension options include an increase of the lease payment mostly in a range of 2%-10%.
|
(4) |
As of December 31, 2017 operating lease agreements in respect of vehicles are for periods of up to three years. The rental payments are linked to the Israeli CPI.
|
(5) |
Non-cancelable minimum operating lease rentals (undiscounted) in respect of all the above leases are payable including option periods which are reasonably certain are as follows:
|
New Israeli Shekels
|
||||
December 31, 2017
|
||||
In millions
|
||||
2018
|
158
|
|||
2019
|
100
|
|||
2020
|
77
|
|||
2021
|
59
|
|||
2022-2023
|
100
|
|||
2024-2025
|
52
|
|||
2026-2027
|
13
|
|||
2028 and thereafter
|
19
|
|||
578
|
(6) |
The rental expenses for the years ended December 31, 2015, 2016 and 2017 were approximately NIS 260 million, NIS 213 million, and NIS 178 million, respectively. Commencing April 2016, rent expenses of cell sites of the Company, Hot Mobile and PHI are divided between the Company and Hot Mobile, through PHI, according to the OPEX-CAPEX mechanism (see also note 9).
|
A. |
Claims
|
1. |
Consumer claims
|
Claim amount
|
Number of claims
|
Total claims amount (NIS million)
|
||||||
Up to NIS 100 million
|
26
|
640
|
||||||
NIS 100 - 400 million
|
6
|
1,330
|
||||||
NIS 400 million - NIS 1 billion
|
2
|
1,405
|
||||||
Unquantified claims
|
13
|
-
|
||||||
Total
|
47
|
3,375
|
1. |
On April 13, 2011, a claim and a motion to certify the claim as a class action were filed against Partner. The claim alleges that Partner sent a message to its customers that their internet package was fully utilized before it was fully utilized. The amount claimed in the lawsuit was estimated by the plaintiffs to be approximately NIS 4.6 million. In June 2013, the Court approved the motion and recognized the lawsuit as a class action. In August 2013, Partner filed a request to appeal to the Supreme Court. In February 2014, the Supreme Court dismissed Partner's request, and a hearing has been set. In January 2015, the parties filed a request to approve a settlement agreement. In July 2015, the parties filed an amended request to approve the settlement agreement. In June 2016 the Court approved the request and in February 2018 the parties filed a request to the Court regarding the completion of the settlement agreement. The damages that Partner was required to pay were immaterial.
|
2. |
On September 7, 2010, a claim and a motion to certify the claim as a class action were filed against Partner. The claim alleges that Partner unlawfully charged its customers for services of various content providers which are sent through text messages (SMS). The total amount claimed from Partner is estimated by the plaintiffs to be approximately NIS 405 million. The claim was certified as a class action in December 2016. In February 2017, the plaintiffs filed an appeal to the Supreme Court, regarding the definition of the group of customers. Partner estimates that even if the claim will be decided in favor of the approved group of customers (as defined by the District Court), the damages that Partner will be required to pay for, will be immaterial.
|
3. |
On April 3, 2012, a claim and a motion to certify the claim as a class action were filed against Partner. The claim alleges that Partner breached its license conditions in connection with benefits provided to customers that purchased handsets from third parties. The amount claimed in the lawsuit was estimated by the plaintiffs to be approximately NIS 22 million. In September 2014, The Court approved the motion and recognized the lawsuit as a class action. In July 2017, the parties filed a request to the Court to approve a settlement agreement. Partner estimates that the damages that Partner will be required to pay for will be immaterial.
|
2. |
Employees and other claims
|
B. |
Contingencies in respect of building and planning procedures
|
(1) |
Under the Telegraph Regulations the Company is committed to pay an annual fixed fee for each frequency used. Under the above Regulations should the Company choose to return a frequency, such payment is no longer due.
|
(2) |
Section 197 of the Building and Planning Law states that a property owner has the right to be compensated by a local planning committee for reductions in property value as a result of a new building plan.
|
a. |
Share capital:
|
b. |
Share based compensation to employees
|
(1) |
Description of the Equity Incentive Plan
|
b. |
Share based compensation to employees (continued)
|
(1) |
Description of the Equity Incentive Plan (continued)
|
- |
Exercise price adjustment: The exercise price of options shall be reduced in the following events: (1) dividend distribution other than in the ordinary course: by the gross dividend amount so distributed per share, and (2) dividend distribution in the ordinary course: the exercise price shall be reduced by the amount of a dividend in excess of 40% of the Company’s net income for the relevant period per share, or by the gross dividend amount so distributed per share ("Full Dividend Mechanism"), depending on the date of granting of the options.
|
- |
Cashless exercise: Most of the options may be exercised only through a cashless exercise procedure, while holders of other options may choose between cashless exercise and the regular option exercise procedure. In accordance with such cashless exercise, the option holder would receive from the Company, without payment of the exercise price, only the number of shares whose aggregate market value equals the economic gain which the option holder would have realized by selling all the shares purchased at their market price, net of the option exercise price.
|
(2) |
Information in respect of options and restricted shares granted under the Plan:
|
Through December 31, 2017
|
||||||||
Number of options
|
Number of RSAs
|
|||||||
Granted
|
31,304,207
|
4,298,768
|
||||||
Shares issued upon exercises and vesting
|
(6,430,589
|
)
|
(1,617,518
|
)
|
||||
Cancelled upon net exercises, expiration and forfeitures
|
(16,165,135
|
)
|
(1,336,953
|
)
|
||||
Outstanding
|
8,708,483
|
1,344,297
|
||||||
Of which:
|
||||||||
Exercisable
|
5,190,586
|
26,556
|
||||||
Vest in 2018
|
2,502,089
|
891,309
|
||||||
Vest in 2019
|
667,254
|
280,115
|
||||||
Vest in 2020
|
348,554
|
146,317
|
b. |
Share based compensation to employees (continued)
|
(3) |
Options and RSAs status summary as of December 31, 2015, 2016 and 2017 and the changes therein during the years ended on those dates:
|
Year ended December 31
|
||||||||||||||||||||||||
2015
|
2016
|
2017
|
||||||||||||||||||||||
Number |
Weighted average
exercise price |
Number |
Weighted average
exercise price |
Number |
Weighted average
exercise price |
|||||||||||||||||||
Share Options:
|
NIS
|
NIS
|
NIS
|
|||||||||||||||||||||
Outstanding at the beginning of the year
|
8,962,116
|
32.08
|
12,686,317
|
29.52
|
11,285,901
|
29.14
|
||||||||||||||||||
Granted during the year
|
5,519,031
|
17.41
|
998,433
|
18.14
|
1,201,358
|
19.45
|
||||||||||||||||||
Exercised during the year
|
(32,880
|
)
|
13.12
|
(284,251
|
)
|
15.74
|
(1,906,991
|
)
|
17.38
|
|||||||||||||||
Forfeited during the year
|
(1,459,215
|
)
|
28.7
|
(1,219,648
|
)
|
20.58
|
(988,566
|
)
|
22.91
|
|||||||||||||||
Expired during the year
|
(302,735
|
)
|
58.61
|
(894,950
|
)
|
38.16
|
(883,219
|
)
|
43.10
|
|||||||||||||||
Outstanding at the end of the year
|
12,686,317
|
29.52
|
11,285,901
|
29.14
|
8,708,483
|
29.67
|
||||||||||||||||||
Exercisable at the end of the year
|
4,615,076
|
45.97
|
5,912,904
|
37.77
|
5,190,586
|
36.66
|
||||||||||||||||||
Shares issued during the year due exercises
|
8,496
|
47,484
|
319,259
|
|||||||||||||||||||||
RSAs:
|
||||||||||||||||||||||||
Outstanding at the beginning of the year
|
1,589,990
|
2,900,626
|
1,955,414
|
|||||||||||||||||||||
Granted during the year
|
1,779,596
|
417,176
|
507,146
|
|||||||||||||||||||||
Vested during the year
|
(6,015
|
)
|
(858,397
|
)
|
(753,106
|
)
|
||||||||||||||||||
Forfeited during the year
|
(462,945
|
)
|
(503,991
|
)
|
(365,157
|
)
|
||||||||||||||||||
Outstanding at the end of the year
|
2,900,626
|
1,955,414
|
1,344,297
|
Options granted in 2015
|
Options granted in 2016
|
Options granted in 2017
|
||||||||||
Weighted average fair value of options granted using the
|
||||||||||||
Black & Scholes option-pricing model – per option (NIS)
|
5.37
|
5.02
|
5.43
|
|||||||||
The above fair value is estimated on the grant date based on the following weighted average assumptions:
|
||||||||||||
Expected volatility
|
39.28
|
%
|
39.5
|
%
|
37.6
|
%
|
||||||
Risk-free interest rate
|
0.54
|
%
|
0.54
|
%
|
0.53
|
%
|
||||||
Expected life (years)
|
3
|
3
|
3
|
|||||||||
Dividend yield
|
*
|
*
|
*
|
b. |
Share based compensation to employees (continued)
|
(4) |
Information about outstanding options by expiry dates
|
Expire in |
Number of share options
|
Weighted average exercise price in NIS
|
|||||||
2018
|
371,687
|
25.55
|
|||||||
2019
|
1,191,771
|
49.77
|
|||||||
2020
|
2,324,841
|
37.66
|
|||||||
2021
|
2,947,959
|
21.69
|
|||||||
2022
|
826,533
|
21.66
|
|||||||
2023
|
1,045,692
|
19.26
|
|||||||
8,708,483
|
29.67
|
(a) |
Revenues:
|
New Israeli Shekels in millions
|
||||||||
Deferred revenues from Hot mobile *
|
Other deferred revenues*
|
|||||||
Balance as at December 31, 2016
|
226
|
45
|
||||||
Revenue recognized that was included in the contract liability balance at the beginning of the year
|
(31
|
)
|
(29
|
)
|
||||
Increases due to cash received, excluding amounts recognized as revenues during the year
|
-
|
30
|
||||||
Balance as at December 31, 2017
|
195
|
46
|
Year ended December 31, 2017
New Israeli Shekels in millions |
||||||||||||||||
Cellular segment
|
Fixed-line segment
|
Elimination
|
Consolidated
|
|||||||||||||
Segment revenue - Services to private customers
|
1,173
|
254
|
(32
|
)
|
1,395
|
|||||||||||
Segment revenue - Services to business customers
|
805
|
523
|
(141
|
)
|
1,187
|
|||||||||||
Segment revenue - Services revenue total
|
1,978
|
777
|
(173
|
)
|
2,582
|
|||||||||||
Segment revenue - Equipment
|
610
|
76
|
686
|
|||||||||||||
Total Revenues
|
2,588
|
853
|
(173
|
)
|
3,268
|
(b)
|
Cost of revenues
|
New Israeli Shekels
|
||||||||||||
Year ended December 31,
|
||||||||||||
2015
|
2016
|
2017
|
||||||||||
In millions
|
||||||||||||
Transmission, communication and content providers
|
888
|
814
|
738
|
|||||||||
Cost of equipment and accessories
|
852
|
625
|
519
|
|||||||||
Depreciation and amortization (including impairment)
|
577
|
501
|
477
|
|||||||||
Wages, employee benefits expenses and car maintenance
|
320
|
270
|
293
|
|||||||||
Costs of handling, replacing or repairing equipment
|
88
|
93
|
75
|
|||||||||
Operating lease, rent and overhead expenses
|
315
|
258
|
184
|
|||||||||
Network and cable maintenance
|
145
|
150
|
97
|
|||||||||
Internet infrastructure and service providers
|
49
|
68
|
95
|
|||||||||
Car kit installation, IT support, and other operating expenses
|
72
|
62
|
61
|
|||||||||
Amortization of rights of use (including impairment)
|
112
|
30
|
40
|
|||||||||
Other
|
54
|
53
|
48
|
|||||||||
Total cost of revenues
|
3,472
|
2,924
|
2,627
|
(c)
|
Selling and marketing expenses
|
New Israeli Shekels
|
||||||||||||
Year ended December 31,
|
||||||||||||
2015
|
2016
|
2017
|
||||||||||
In millions
|
||||||||||||
Wages, employee benefits expenses and car maintenance
|
206
|
177
|
(*)106
|
|||||||||
Advertising and marketing
|
30
|
68
|
44
|
|||||||||
Selling commissions, net
|
77
|
82
|
(*)29
|
|||||||||
Depreciation and amortization (including impairment)
|
55
|
55
|
(*)54
|
|||||||||
Operating lease, rent and overhead expenses
|
27
|
29
|
23
|
|||||||||
Other
|
22
|
15
|
13
|
|||||||||
Total selling and marketing expenses
|
417
|
426
|
269
|
(d)
|
General and administrative expenses
|
New Israeli Shekels
|
||||||||||||
Year ended December 31,
|
||||||||||||
2015
|
2016
|
2017
|
||||||||||
In millions
|
||||||||||||
Wages, employee benefits expenses and car maintenance
|
84
|
101
|
79
|
|||||||||
Bad debts and allowance for doubtful accounts
|
63
|
82
|
52
|
|||||||||
Professional fees
|
31
|
32
|
22
|
|||||||||
Credit card and other commissions
|
16
|
14
|
14
|
|||||||||
Depreciation
|
9
|
9
|
9
|
|||||||||
Other
|
20
|
25
|
20
|
|||||||||
Total general and administrative expenses
|
223
|
263
|
196
|
(e)
|
Employee benefit expense
|
New Israeli Shekels
|
||||||||||||
Year ended December 31,
|
||||||||||||
2015
|
2016
|
2017
|
||||||||||
In millions
|
||||||||||||
Wages and salaries including social benefits, social
|
||||||||||||
security costs, pension costs and car maintenance
|
||||||||||||
before capitalization
|
622
|
537
|
503
|
|||||||||
Less: expenses capitalized (notes 10, 11)
|
(65
|
)
|
(65
|
)
|
(77
|
)
|
||||||
Service costs: defined benefit plan (note 16(2))
|
21
|
17
|
15
|
|||||||||
Service costs: defined contribution plan (note 16(1))
|
15
|
14
|
17
|
|||||||||
Employee share based compensation expenses (note 21(b))
|
17
|
45
|
20
|
|||||||||
610
|
548
|
478
|
New Israeli Shekels
Year ended December 31,
|
||||||||||||
2015
|
2016
|
2017
|
||||||||||
In millions
|
||||||||||||
Unwinding of trade receivables
|
46
|
41
|
27
|
|||||||||
Other income, net
|
1
|
4
|
4
|
|||||||||
47
|
45
|
31
|
New Israeli Shekels
|
||||||||||||
Year ended December 31,
|
||||||||||||
2015
|
2016
|
2017
|
||||||||||
In millions
|
||||||||||||
Net foreign exchange rate gains
|
7
|
2
|
||||||||||
Fair value gain from derivative financial instruments, net
|
2
|
*
|
*
|
|||||||||
CPI linkage income
|
9
|
2
|
||||||||||
Interest income from cash equivalents
|
1
|
1
|
2
|
|||||||||
Other
|
1
|
3
|
*
|
|||||||||
Finance income
|
13
|
13
|
4
|
|||||||||
|
||||||||||||
Interest expenses
|
136
|
105
|
171
|
|||||||||
CPI linkage expenses
|
4
|
|||||||||||
Net foreign exchange rate losses
|
9
|
|||||||||||
Other finance costs
|
11
|
13
|
9
|
|||||||||
Finance expenses
|
156
|
118
|
184
|
|||||||||
143
|
105
|
180
|
a. |
Measurement of results for tax purposes under the Income Tax (Inflationary Adjustments) Law, 1985
|
b. |
Corporate income tax rates applicable to the Group
|
c. |
Deferred income taxes
|
Balance of deferred tax asset (liability) in respect of
|
As at January 1, 2015
|
Charged to the income statement
|
Charged to other comprehen-sive income
|
As at December 31, 2015
|
Charged to the income statement
|
Charged to other comprehensive income
|
Effect of change in corporate tax rate
|
As at December 31, 2016
|
Charged to the income statement
|
Charged to other comprehensive income
|
As at December 31, 2017
|
|||||||||||||||||||||||||||||||||
Allowance for doubtful accounts
|
44
|
1
|
45
|
6
|
(6
|
)
|
45
|
*
|
45
|
|||||||||||||||||||||||||||||||||||
Provisions for employee rights
|
19
|
(4
|
)
|
(1
|
)
|
14
|
*
|
2
|
(2
|
)
|
14
|
*
|
1
|
15
|
||||||||||||||||||||||||||||||
Depreciable fixed assets and software
|
(70
|
)
|
17
|
(53
|
)
|
13
|
5
|
(35
|
)
|
8
|
(27
|
)
|
||||||||||||||||||||||||||||||||
Intangibles, deferred expenses and carry forward losses
|
7
|
15
|
22
|
(8
|
)
|
(5
|
)
|
9
|
7
|
16
|
||||||||||||||||||||||||||||||||||
Options granted to employees
|
1
|
2
|
3
|
4
|
(1
|
)
|
6
|
*
|
6
|
|||||||||||||||||||||||||||||||||||
Other
|
9
|
9
|
18
|
(18
|
)
|
2
|
2
|
(2
|
)
|
*
|
||||||||||||||||||||||||||||||||||
Total
|
10
|
40
|
(1
|
)
|
49
|
(3
|
)
|
2
|
(7
|
)
|
41
|
13
|
1
|
55
|
c. |
Deferred income taxes (continued)
|
New Israeli Shekels
|
||||||||
December 31,
|
||||||||
2016
|
2017
|
|||||||
In millions
|
||||||||
Deferred tax assets
|
||||||||
Deferred tax assets to be recovered after more than 12 months
|
87
|
80
|
||||||
Deferred tax assets to be recovered within 12 months
|
37
|
50
|
||||||
124
|
130
|
|||||||
Deferred tax liabilities
|
||||||||
Deferred tax liabilities to be recovered after more than 12 months
|
72
|
63
|
||||||
Deferred tax liabilities to be recovered within 12 months
|
11
|
12
|
||||||
83
|
75
|
|||||||
Deferred tax assets, net
|
41
|
55
|
d. |
Following is a reconciliation of the theoretical tax expense, assuming all income is taxed at the regular tax rates applicable to companies in Israel (see (b) above), and the actual tax expense:
|
New Israeli Shekels
|
||||||||||||
Year ended December 31
|
||||||||||||
2015
|
2016
|
2017
|
||||||||||
In millions
|
||||||||||||
Profit (loss) before taxes on income,
|
||||||||||||
as reported in the income statements
|
(36
|
)
|
88
|
135
|
||||||||
Theoretical tax expense
|
(9
|
)
|
22
|
32
|
||||||||
Increase in tax resulting from disallowable deductions
|
7
|
11
|
8
|
|||||||||
Taxes on income in respect of previous years
|
7
|
(4
|
)
|
(10
|
)
|
|||||||
Change in corporate tax rate, see (b) above
|
7
|
|||||||||||
Temporary differences and tax losses for which no deferred income
|
||||||||||||
tax asset was recognized
|
(9
|
)
|
||||||||||
Other
|
(1
|
)
|
*
|
*
|
||||||||
Income tax expenses
|
4
|
36
|
21
|
e. |
Taxes on income included in the income statements:
|
New Israeli Shekels
|
||||||||||||
Year ended December 31
|
||||||||||||
2015
|
2016
|
2017
|
||||||||||
In millions
|
||||||||||||
For the reported year:
|
||||||||||||
Current
|
37
|
31
|
44
|
|||||||||
Deferred, see (c) above
|
(40
|
)
|
2
|
(4
|
)
|
|||||||
Effect of change in corporate tax rate on deferred taxes
|
7
|
|||||||||||
In respect of previous year:
|
||||||||||||
Current
|
7
|
(4
|
)
|
(10
|
)
|
|||||||
Deferred, see (c) above
|
(9
|
)
|
||||||||||
4
|
36
|
21
|
f. |
Tax assessments:
|
1) |
The Company has received final corporate tax assessments through the year ended December 31, 2015. During 2017, the Company received final tax assessments for the years 2014 and 2015.
|
2) |
A subsidiary has received final corporate tax assessments through the year ended December 31, 2013.
|
3) |
As general rule, tax self-assessments filed by another two subsidiaries through the year ended December 31, 2012 are, by law, now regarded as final.
|
a. |
Key management compensation
|
New Israeli Shekels
|
||||||||||||
Year ended December 31
|
||||||||||||
2015
|
2016
|
2017
|
||||||||||
Key management compensation expenses comprised
|
In millions
|
|||||||||||
Salaries and short-term employee benefits
|
23
|
22
|
21
|
|||||||||
Long term employment benefits
|
4
|
3
|
3
|
|||||||||
Employee share-based compensation expenses
|
4
|
17
|
11
|
|||||||||
31
|
42
|
35
|
New Israeli Shekels
|
||||||||
December 31,
|
||||||||
2016
|
2017
|
|||||||
Statement of financial position items - key management
|
In millions
|
|||||||
Current liabilities:
|
10
|
11
|
||||||
Non-current liabilities:
|
12
|
11
|
b. |
In the ordinary course of business, key management or their relatives may have engaged with the Company with immaterial transactions that are under normal market conditions.
|
c. |
Principal shareholder: On January 29, 2013, S.B. Israel Telecom Ltd. completed the acquisition of 48,050,000 ordinary shares of the Company and became the Company's principal shareholder. See also note 1(a). As of December 31, 2017 the principal shareholder held 49,862,800 ordinary shares including the shares issued in June 2017. See also note 21(a).
|
d. |
Associates – investment in PHI
|
New Israeli Shekels
|
||||||||
Year ended December 31
|
||||||||
2016
|
2017
|
|||||||
In millions
|
||||||||
Cost of revenues
|
(2
|
)
|
45
|
New Israeli Shekels
|
||||||||
December 31,
|
||||||||
2016
|
2017
|
|||||||
In millions
|
||||||||
Deferred expenses - Right of use
|
41
|
95
|
||||||
Current assets (liabilities)
|
(5
|
)
|
(43
|
)
|
||||
Non-current assets (liabilities)
|
(7
|
)
|
Year ended December 31
|
||||||||||||
2015
|
2016
|
2017
|
||||||||||
Profit (loss) used for the computation of
|
||||||||||||
basic and diluted EPS (NIS in millions)
|
(40
|
)
|
52
|
114
|
||||||||
Weighted average number of shares used
|
||||||||||||
in computation of basic EPS (in thousands)
|
156,081
|
156,268
|
162,733
|
|||||||||
Add - net additional shares from assumed
|
||||||||||||
exercise of employee stock options and restricted
|
||||||||||||
shared (in thousands)
|
0
|
1,828
|
1,804
|
|||||||||
Weighted average number of shares used in
|
||||||||||||
computation of diluted EPS (in thousands)
|
156,081
|
158,096
|
164,537
|
|||||||||
Number of options and restricted shares not taken into
|
||||||||||||
account in computation of diluted earnings per share,
|
||||||||||||
because of their anti-dilutive effect (in thousands)
|
15,587
|
8,906
|
5,650
|
New Israeli Shekels
|
||||||||
Year ended December 31,
|
||||||||
2016
|
2017
|
|||||||
In millions
|
||||||||
Service revenues
|
2,752
|
2,582
|
||||||
Equipment revenues
|
792
|
686
|
||||||
Total revenues
|
3,544
|
3,268
|
||||||
Cost of revenues – Services
|
2,276
|
2,083
|
||||||
Cost of revenues – Equipment
|
648
|
544
|
||||||
Total Cost of revenues
|
2,924
|
2,627
|
||||||
Gross profit
|
620
|
641
|
1. |
Partner Communications Company Ltd. (“Partner”) hereby undertakes to indemnify you for any liability or expense that you incur or that is imposed on you in consequence of an action or an inaction by you (including prior to the date of this letter), in your capacity of an officer or director in Partner or as an officer or director on behalf of Partner in a company controlled by Partner or in which Partner has a direct or indirect interest (such companies being referred to herein as “Subsidiaries”), as follows:
|
1.1. |
Financial liability that you incur or is imposed on you in accordance with a judgment, including a judgment given in a settlement or a judgment of an arbitrator approved by the court; provided, that such liability pertains to one or more of the events set out in Schedule I hereto, which, in the opinion of the Board of Directors of Partner, are anticipated in light of Partner's activities at the time of granting this undertaking and are at the sum or measurement of indemnification determined by the Board of Directors to be reasonable given the circumstances set forth herein;
|
1.2. |
Reasonable litigation expenses, including legal fees, that you may incur or for which you will be ordered to pay by a court in the context of proceedings filed against you by or on behalf of Partner or by a third party, or in a criminal proceeding in which you are acquitted or if you are convicted, for an offense which does not require criminal intent; and
|
1.3. |
Reasonable litigation expenses, including legal fees that you may incur due to an investigation or proceeding conducted against you by an authority authorized to conduct such investigation or proceeding and which has ended without the filing of an indictment against you and either (i) no financial liability was imposed on you in lieu of criminal proceedings, or (ii) financial liability was imposed on you in lieu of criminal proceedings but the alleged criminal offense does not require proof of criminal intent, within the meaning of the relevant terms in or in the law referred to in the Israeli Companies Law of 1999 (the “Israeli Companies Law”), or in relation to a financial sanction ("itzum caspi").
|
1.4. | Payment to the harmed party as a result of a violation set forth in Section 52.54(a)(1)(a) ((52נד(א)(1)(א) of the Israeli Securities Law of 1968 (the "Israeli Securities Law"), including by indemnification in advance. |
1.5. | Expenses incurred in connection with a Procedure ("halich"), as defined in Section 56.8(a)(1) (56ח(א)(1)) of the Israeli Securities Law (a "Procedure"), in connection with any of your affairs including, without limitation, reasonable litigation expenses, including legal fees, including by indemnification in advance. |
1.5A |
Expenses that you may incur with respect to a proceeding in accordance with the Restrictive Trade Practices Law of 1988, including reasonable litigation expenses that include attorney fees.
|
1.6. | Any other liability or expense indemnifiable under any applicable law. |
2. |
Partner may not indemnify you for your liability for: (i) a breach of duty of loyalty towards Partner unless you have acted in good faith and had reasonable grounds to assume that the action would not harm Partner's best interest; (ii) a breach of duty of care done intentionally or recklessly ("pzizut") except for negligence; (iii) an act intended to unlawfully yield a personal profit; (iv) a fine, a civil fine ("knass ezrahi"), a financial sanction ("itzum caspi") or a penalty ("kofer") imposed upon you; and (v) a Procedure ("halich").
|
3. |
Indemnification pursuant to this letter will be subject to applicable law and to the following terms and conditions:
|
3.1.
|
That you notify Partner within a reasonable time of your learning of any legal proceedings instigated against you in connection with any event that may give rise to indemnification and that you provide Partner, or anyone specified by Partner, with any documents connected to the proceeding in question.
|
3.2.
|
That Partner reserves the right to represent you in the proceedings or to appoint legal counsel of its choice for this purpose (unless its choice of legal counsel is unacceptable to you on reasonable grounds). Partner or such legal counsel will take all necessary steps to bring the matter to a close and will keep you informed of key steps in the process. The appointed counsel will be bound by a fiduciary duty to you and to Partner. If a conflict of interests should arise between the appointed counsel and yourself, counsel will inform Partner and you will be entitled to appoint a different counsel reasonably acceptable to Partner and the terms of this indemnification agreement shall apply to the new appointment. If Partner should decide to settle by arbitration or by mediation or by settlement, it shall be allowed to do so; provided, that you do not incur any additional expense or liability due to such arbitration, mediation or settlement or that you have otherwise agreed to such arbitration, mediation or settlement. If Partner so requests, you will sign any document that will empower it or any appointed counsel to represent you and defend you in any proceeding as stated above. You will cooperate as reasonably demanded of you with Partner and any appointed legal counsel. Partner shall cover all related expenses so that you will not have to make any payments or incur any expenses yourself. |
3.3. |
That whether or not Partner shall operate in accordance with section 3.2 above, indemnification shall still cover all and every kind of expense incurred by you that is included in section 1 of this letter so that you will not have to pay or finance them yourself. You will not be indemnified for any expenses arising from a settlement, mediation or arbitration unless Partner has agreed to the settlement, mediation or arbitration.
|
3.4. |
That upon your request for payment in connection with any event according to this indemnification letter, Partner shall complete all the necessary arrangements required by the law for payment and shall act to receive all necessary authorizations, if demanded. If any authorization should be required for payment, and the payment is not authorized for any reason, this payment or part of it will be subject to the approval of the court (if relevant) and Partner shall act in order to receive authorization.
|
3.5. |
That in the event that you are paid for any sums in accordance with this letter of indemnification and release in connection with a legal proceeding, and later it becomes clear that you were not entitled to such payments, the sums will be considered as a loan given to you by Partner subject to the lowest interest rate for purposes of Section 3(9) of the Income Tax Ordinance (or any other legislation replacing it) which does not cause a taxable benefit. You shall be required to repay such amounts in accordance with the payment arrangements fixed by Partner, and at such time as Partner shall request in writing.
|
3.6 |
That you shall remain entitled to indemnification by Partner as provided in this letter of indemnification and release even when you are no longer an officer or director in Partner or in a Subsidiary on Partner’s behalf, as long as the events that led to the payments, costs and expenses for which indemnification is being sought are a result of an action or an inaction taken by you as such officer or director.
|
3.7 |
The terms contained in this letter will be construed in accordance with the Israeli Companies Law and in the absence of any definition in the Israeli Companies Law, pursuant to the Israeli Securities Law. Schedule I hereto constitutes an integral part hereof.
|
3.8 |
The obligations of Partner under this letter shall be interpreted broadly and in a manner that shall facilitate its implementation, to the fullest extent permitted by law, including, ipso facto, as further expanded in the future, and for the purposes for which it was intended. Without derogating from the generality of the foregoing, it is clarified that with respect to any expansion of indemnification that is currently, or will in the future be, permitted by law following incorporation of specific provisions in Partner’s Articles of Association, such expansion be in effect ipso facto even prior to such incorporation, based on Article 34.1 of the Articles of Association, which allows indemnification to the fullest extent permitted by law. In the event of a conflict between any provision of this letter and any provision of the law that cannot be superseded, changed or amended, said provision of the law shall supersede the specific provision in this letter, but shall not limit or diminish the validity of the remaining provisions of this letter.
|
3.9 |
The indemnification under this letter will enter into effect upon your signing a copy of the same in the appropriate place, and the delivery of such signed copy to Partner. It is hereby agreed that your agreement to accept this letter constitutes your irrevocable agreement that any previous undertaking of Partner for indemnification towards you, to the extent granted, shall become void automatically upon your signing this letter. Notwithstanding the above, if this letter shall be declared or found void for any reason whatsoever, then any previous undertaking of Partner for indemnification towards you, which this letter is intended to replace, shall remain in full force and effect.
|
3.10 |
Partner may, in its sole discretion and at any time, revoke its undertaking to indemnify hereunder, or reduce the Maximum Indemnity Amount (as defined in section 3.13 below) thereunder, or limit the events to which it applies, either in regard to all the officers or to some of them, to the extent such change or revocation relates solely to events that occur after the date of such change; provided, that prior notice has been given to you of its intention to do so, in writing, at least 60 days before the date on which its decision will enter into effect. No such decision will have a retroactive effect of any kind whatsoever, and the letter of indemnification and release prior to such change or revocation, as the case may be, will continue to apply and be in full force and effect for all purposes in relation to any event that occurred prior to such change or revocation, even if the proceeding in respect thereof is filed against you after the change or revocation of the letter of indemnification and release. In all other cases, this letter may not be changed unless Partner and you have agreed in writing.
|
3.11 |
This undertaking to indemnify is not a contract for the benefit of any third party, including any insurer, and is not assignable nor will any insurer have the right to demand participation of Partner in any payment for which an insurer is made liable under any insurance agreement that has been made with it, with the exception of the deductible specified in such agreement. For the avoidance of any doubt in the event of death this letter will apply to you and your estate.
|
3.12 |
No waiver, delay, forbearance to act or extension granted by Partner or by you will be construed in any circumstance as a waiver of the rights hereunder or by law, and will not prevent any such party from taking all legal and other steps as will be required in order to enforce such rights.
|
3.13 |
The aggregate indemnification amount payable by Partner to all directors, officers and other indemnified persons (including, inter alia, officers and directors nominated on behalf of Partner in Subsidiaries), pursuant to all letters of indemnification issued to them by Partner on or after October 17, 2013, which indemnification letters include a maximum indemnity amount substantially similar to the Maximum Indemnity Amount under this Section 3.13 (the “Maximum Indemnity Amount”), for any occurrence of an event set out in Schedule I hereto (each, an “Event”), will not exceed 25% of shareholders equity (according to the latest reviewed or audited financial statements approved by Partner's Board of Directors prior to approval of the indemnification payment); provided, however, that under the circumstances where indemnification for the same Event is to be made in parallel to you under this letter and to one or more indemnified persons under indemnification letters issued (or to be issued) by Partner containing a maximum indemnity amount which is the higher of 25% of shareholders equity and 25% of market capitalization (the "Combined Maximum Indemnity Amount"), the Maximum Indemnity Amount for you hereby shall be adjusted so it does not exceed the Combined Maximum Indemnity Amount to which any other indemnified person is entitled under any other indemnification letter containing the Combined Maximum Indemnity Amount.
|
3.14 |
The Maximum Indemnity Amount shall not be affected in any way by the existence of, or payment under, insurance policies. Payment of the indemnification shall not affect your right to receive insurance payments, if you receive the same (either personally or through Partner or on your behalf) and Partner will not be required to indemnity you for any sums that were, in fact, already paid to you or for you in respect of insurance or any other indemnification obligations made to you by any third party. In the event there is any payment made under this letter and such payment is covered by an insurance policy, Partner shall be entitled to collect such amount of payment from the insurance proceeds. You will return to Partner any amount that you may receive pursuant to this letter, which is based on data or financial results that will later on be found to be erroneous and will be restated in Partner's financial statements, as will be implemented by Partner's Board of Directors.
|
3.15 |
If the indemnification amount Partner is required to pay to its directors and other indemnified persons, as mentioned in section 1 above, exceeds at any time the Maximum Indemnity Amount or the balance of the Maximum Indemnity Amount in accordance with section 3.13 above after deducting any indemnification amounts paid or payable by Partner to any of its directors or other indemnified persons at such time (all, as determined and clarified in Section 3.13 above or in the other applicable indemnification letters), such Maximum Indemnification Amount or remaining balance will be allocated among the directors and the other indemnified persons entitled to indemnification, in the same ratio as with respect to any Event the amount for which each individual director or other indemnified person may be indemnified is to the aggregate amount that all of the relevant directors and other indemnified persons involved in the Event may be indemnified.
|
3.16 |
The foregoing does not derogate from Partner's right to indemnify you retroactively in accordance with that permitted by the Articles of Association of Partner and applicable law.
|
4.
|
Release
|
4.1 |
The Company releases you in advance, subject to the provisions of the Companies Law, from your liability towards the Company for any damage caused and/or that will be caused to the Company, insofar as will be caused, in consequence of the breach of your duty of care toward the Company while acting in good faith, in your capacity as an officer or director in Partner or the Subsidiaries for the events and to the extent that will be allowed at the time of release by law. The said release from liability will be for amounts for which the officers or directors are not entitled to indemnification in accordance with the Company's D&O insurance policy.
|
4.2 |
Partner may not release you for your liability for: (i) a breach of duty of loyalty towards Partner unless you have acted in good faith and had reasonable grounds to assume that the action would not harm Partner's best interest; (ii) a breach of duty of care done intentionally or recklessly ("pzizut") except for negligence; (iii) an act intended to unlawfully yield a personal profit; (iv) a fine, a civil fine ("knass ezrahi"), a financial sanction ("itzum caspi") or a penalty ("kofer") imposed upon you and (v) a breach of duty of care in a Distribution ("haluka").
|
4.3 |
In addition to the limitations of the release according to any law, the release shall not apply to the following cases:
|
a. |
Any counterclaim of the Company against an officer or director as a result of a claim of an officer or director against the Company, except for when the claim of the officer is to protect his rights that stem from labor law in accordance with the law or a personal employment agreement between himself and the Company or a resolution duly adopted by the Company's organs in respect of directors remuneration.
|
b. |
Resolution or transaction in which the controlling shareholder or any officer or director in the Company (including other officers or directors than the officer or director being granted the release) has a personal interest.
|
5.
|
Sections 3.6-3.9 and 3.11-3.12 above will apply Mutatis Mutandis to release.
|
6.
|
In sections 4 and 5 -"acting" – or any derivative of it as set forth in the Companies Law, including also a decision and/or omission and including all of the actions taken by you before the date of this letter during the periods in which you were employed and/or served as an officer or director of the Company and/or during the periods in which you were an officer, employee or agent of the Company in another corporation in which the Company directly or indirectly holds securities.
|
7.
|
For the avoidance of doubt, it hereby determined that this letter of indemnification and release shall not cancel or derogate or constitute a waiver of any other indemnification that the officer or director is entitled to in accordance with the provisions of any law or in accordance with any previous undertaking of the Company and/or previous agreement with the Company, insofar as the said undertaking is legally valid, and from any other resolution of the Company to grant indemnification to an officer or director in the Company. It is hereby clarified that the Company will not be obligated to indemnify an officer or director for the same event, in accordance with any previous undertaking (if and insofar as it will be valid) as well as in accordance with this letter of indemnification and release. In any case in which an officer or director can be indemnified, by law, both in accordance with this Letter of indemnification and release and a previous undertaking of the Company, the Company's Audit Committee (and insofar as the majority of its members have a Personal Interest, a special committee of two directors that do not have a Personal interest shall be formed) shall decide, subject to all legal provisions, according to which undertaking the officer or director should be indemnified.
|
1. |
Any offering of Partner’s securities to private investors and/or to the public and listing of such securities, and/or the offer by Partner to purchase securities from the public and/or from private investors or other holders, and any undertakings, representations, warranties and other obligations related to any such offering and Partner’s status as a public company or as an issuer of securities.
|
2. |
All matters relating to Partner’s status, obligations and/or actions as a public company, and/or the fact that Partner’s securities were issued to the public or to private investors and/or are or were traded on a stock exchange (including, without limitation, Nasdaq stock market, the Tel Aviv Stock Exchange and the London Stock Exchange), whether in Israel or abroad.
|
3. |
The erection, construction and operation of Partner’s mobile telephone network, including the erection and operation of antennas and other equipment and environmental issues, including undertakings, activities and communications with authorities regarding the foregoing and including the work performed by Partner’s subcontractors in connection therewith.
|
4. |
The purchase, distribution, marketing and sale of handsets, other terminal equipment and any other of Partner’s products and/or any marketing plans and/or publications.
|
5. |
A Transaction, Extraordinary Transaction, or an Activity within the meaning of Section 1 of the Israeli Companies Law, including negotiations for entering into a Transaction or an Activity, the transfer, sale, acquisition or charge of assets or liabilities (including securities) or the grant or acceptance of a right in any one of them, receiving credit and the grant of collateral, as well as any act directly or indirectly involving such a Transaction or Activity.
|
6. |
Investments which Partner and/or its Subsidiaries and/or its affiliates make in other entities whether before and/or after the investment is made, entering into the transaction, the execution, development and monitoring thereof, including actions taken or alleged omissions by you in the name of Partner and/or any subsidiary thereof and/or any affiliates thereof as a director, officer, employee and/or a board observer of the entity which is the subject of the transaction and the like.
|
7. |
The merger acquisition or other business combination or restructuring, or any such proposed transaction and any decision related to it (by Partner or another person) of Partner, any subsidiary thereof and/or any affiliate thereof with, of or into another entity and/or the sale or proposed sale of the operations and/or business, or part thereof, or any dissolution, receivership, creditors' arrangement, stay of proceeding or any similar proceeding, of Partner, any of its Subsidiaries and/or any of its affiliates.
|
8. |
Tender offers for Partner's securities, including in connection with Partner's Board of Directors' opinion regarding a Special Tender Offer as defined in the Israeli Companies Law or refraining from such opinion.
|
9. |
Labor relations and/or employment matters in Partner, its Subsidiaries and/or its affiliates and trade relations of Partner, its Subsidiaries and/or its affiliates, including with independent contractors, customers, suppliers and service providers.
|
10. |
The testing of products developed and/or marketed by Partner, its Subsidiaries and/or its affiliates and/or in connection with the distribution, sale, license or use of such products.
|
11. |
The intellectual property of Partner, its Subsidiaries and/or its affiliates, and its protection, including the registration or assertion of rights to intellectual property and the defense of claims relating to intellectual property infringement.
|
12. |
Actions taken (or alleged omissions) pursuant to or in accordance with the policies and procedures of Partner, its Subsidiaries and/or its affiliates, whether such policies and procedures are published or not.
|
13. |
The borrowing or other receipt of funds and any other financing transaction or arrangement, or any such proposed transaction or arrangement, whether or not requiring the imposition of any pledge or lien.
|
14. |
Any Distribution (“haluka” - as defined in the Israeli Companies Law).
|
15. |
Taking part in or performing tenders.
|
16. |
The making of any statement, including a representation or opinion made by an officer or director of Partner in such capacity whether in public or private, including during meetings of the Board of Directors or any committee thereof.
|
17. |
An act in contradiction to the Articles of Association or Memorandum of Partner.
|
18. |
Any action or omission in connection with voting rights in Partner.
|
19.
|
Any action or decision in relation to work safety and/or working conditions.
|
20.
|
Actions taken pursuant to any of Partner’s licenses, or any breach thereof.
|
21. |
Decisions and/or actions pertaining to the environment and/or the safety of handsets, including radiation or dangerous substances.
|
22. |
A payment to the harmed party as a result of a violation set forth in Section 52.54(a)(1)(a) (52נד(א)(1)(א)) of the Israeli Securities Law.
|
22A.
|
Expenses incurred with respect to a proceeding in accordance with the Restrictive Trade Practices Law of 1988, including reasonable litigation expenses that include attorney fees.
|
23. |
Negotiation for, signing and performance or non-performance of insurance policies.
|
24. |
Events associated with the drawing up and/or approval of financial statements, including the acts or omissions relating to the adoption of financial reports (including International Financial Reporting Standards IFRS), preparation and signing Partner's financial statements, consolidated or on a sole basis, as applicable, as well as the editing or approval of the Directors' report or business plans and forecasts, providing an estimate of the effectiveness of Partner's internal controls and other matters in connection with the financial statements and Directors' report and provision of statements relating to the financial statements.
|
25. |
Events associated with business plans, including pricing, marketing, distribution, directives to employees, customers and suppliers and collaborations with other parties.
|
26. |
Reporting and/or filing of applications or reports, under any applicable law (including immediate reports, periodic or other), disclosure, messaging, providing (or failure to provide) information, statements, declarations, evaluations, presentations, opinions, reviews, requests for approval, or otherwise to any governmental or quasi-governmental authority, stock exchange or regulatory body whether in Israel or abroad.
|
27. |
Actions and any legal process, whether in Israel or abroad, relating, directly or indirectly, to any governmental or quasi-governmental authority, including with respect to trade restrictions, restrictive arrangements, mergers and monopolies.
|
28. |
Investigations conducted against you by any governmental or quasi-governmental authority.
|
29. |
Class actions, including class actions in respect of the environment, consumer protection or complaints, roaming, content services, the Communications Law of 1982, any of Partner’s licenses, Partner’s contracts, and anti-trust, derivative actions or any other legal proceedings against you and/or Partner and/or any of its Subsidiaries in connection with your role and/or activities in Partner or on its behalf.
|
30. |
All matters relating to the change of control transaction, entered into on August 12, 2009, between Advent Investments Pte. Ltd. and Scailex Corporation Ltd. (“Scailex”), under which Scailex agreed to acquire 78,940,104 Ordinary Shares of Partner.
|
31. |
All matters relating to a potential sale of Partner’s securities by any Material Shareholder (“ba’al menaya mahuti”) of Partner.
|
32. |
Transactions or agreements entered into between Partner and any of its shareholders or between shareholders of Partner.
|
33. |
Transfer of information to shareholders or potential shareholders of Partner, including Interested Parties.
|
34. |
All matters relating to breach of Partner contracts.
|
35. |
Activities Partner may pursue in new areas such as transmission services, access to high-speed Internet services, fixed line and long-distance telephony services, cable television and other communication services to subscribers.
|
36. |
Establishment, registration, administration, or making use of registries and information databases, including as required by the provisions of the Protection of Privacy Law of 1981 (including regulations, orders, directives, rules or provisions and instructions) issued by any competent authority or by virtue of those authorities and any decision or other action relating to said law.
|
37. |
A suspicion as to perpetration of an offence and/or breach of a statutory obligation under any law because of an action taken by Partner and that, according to any law, can also be attributed to you and/or because of an action taken by you by virtue of your function as officer or director in Partner and/or that was taken for the sake of Partner and/or on its behalf.
|
38. |
A payment or non-payment to any governmental authority under any applicable law, including the payment of income tax, sales tax, betterment tax on real estate, transfer taxes, excise, value added tax, stamp tax, customs, National Insurance payments, municipal levies, royalty fees or any other fees, levies, financial sanction ("itzum caspi") in connection with any of Partner’s licenses, and including any kind of fines, interest and linkage increments.
|
39. |
Any other actions which can be anticipated for companies of the type of Partner, and which the Board of Directors may deem appropriate.
|
40. |
Any of the foregoing events, relating to your service as an officer or director in any of Partner's Subsidiaries on Partner's behalf.
|
41. |
Any of the foregoing events, as it may relate to 012 Smile Telecom Ltd. or to any company in which it has a direct or indirect interest.
|
21.1 |
A holding of ten percent (10%) or more of any of the Means of Control in the Licensee will not be transferred, either directly or indirectly, either all at once or in parts, unless given the Minister’s prior written consent.
|
21.2 |
None of the said Means of Control, or a part of them, in the Licensee, may be transferred in any way, if as a result of the transfer, control in the Licensee will be transferred from one person to another, unless given the Minister’s prior written consent.
|
21.3 |
No control shall be acquired, either direct or indirect, in the Licensee, and no person, whether on his/her own or together with his/her relative or with those acting with him/her on a regular basis, shall acquire in it ten percent (10%) or more of any of the Means of Control in the Licensee, whether all at once or in parts, unless given the Minister’s prior written consent.
|
21.4 |
1Cancelled
|
21.5 |
2Despite the provisions of sub-clauses 21.1 and 21.3 above, should there occur a transfer or purchase of a percentage of Tradable Means of Control in the Licensee requiring consent under clauses 21.1 and 21.3 (other than a transfer of purchase that results in a transfer of control), without the Minister’s consent having been sought, the Licensee shall report this to the Minister in writing, and shall make an application to the Minister to approve the said transfer or purchase of the Means of Control in the Licensee, within 21 days of the date on which the Licensee became aware of such.
|
21.6 |
Neither the entry into an underwriting agreement relating to the issue or sale of securities to the public, the registration for trading on the securities exchange in Israel or overseas, nor the deposit or registration of securities with a registration company or with a depository agent or a custodian for the purpose of registration of GDRs or ADRs or similar certificates relating to the issue or sale of securities to the public shall in and of themselves be considered as a transfer of Means of Control in the Licensee3.
|
1 |
Amendment No. 52
|
2 |
Amendment No. 3
|
3 |
Amendment No. 4
|
21.7
|
(a) |
Irregular Holdings shall be noted in the Licensee’s members register (the list of shareholders) stating the fact that they are irregular, immediately upon the Licensee’s becoming aware of this, and a notice of the registration shall be given by the Licensee to the holder of such Irregular Holding and to the Minister.
|
(b) |
Irregular Holdings, noted as aforesaid in clause 21.7(a), shall not provide the holder with any rights, and shall be “dormant shares” as defined in Section 308 of the Companies Law 5759-1999, expect in the case of the receipt of a dividend or any other distribution to shareholders (especially the right to participate in an allotment of rights calculated on the basis of holdings of Means of Control in the Licensee, although holdings accumulated as aforesaid shall also be considered as Irregular Holdings), and therefore no action or claim of the activation of a right by virtue of the Irregular Holdings shall have any force, except in the case of the receipt of a dividend or any other distribution as aforesaid.
|
(1) |
A shareholder who takes part in a vote during a meeting of shareholders shall advise the Licensee prior to the vote, or in the case of documentary voting on the voting document, whether his holdings in the Licensee or his voting require consent under clauses 21 and 23 of the License or not; where a shareholder does not so advise, he may not vote and his vote shall not count.
|
(2) |
No director of the Licensee shall be appointed, elected or transferred from office by virtue of an Irregular Holding; should a director be appointed, elected or transferred from office as aforesaid, the said appointment, election or transfer, as the case may be, shall be of no effect.
|
(3) |
Irregular Holdings shall not provide voting rights in the general meeting;
|
(c) |
The provisions of clause 21.7 shall be included in the Articles of Association of the Licensee, including the provisions of clause 21.9, mutatis mutandis.
|
21.8 |
For so long as the Articles of Association of the Licensee provide as set out in clause 21.7, and the Licensee acts in accordance with the provisions of clauses 21.5 and 21.7, and for so long as none of the holdings of Founding Shareholders or their Substitutes4 reduces to less than 26% 5 6 7 of all Means of Control in the Licensee immediately prior to the listing of the shares for trade, and for so long as the Articles of Association of the Licensee provide that a majority of the voting power in the general meeting of the Licensee may appoint all members of the Board of Directors of the Licensee, other than external directors required by any law and/or the relevant Exchange Rules, the Irregular Holdings shall not, in and of themselves, give rise to a cause for the cancellation of the Licensee.
|
21.9 |
The provisions of clauses 21.5 through 21.8 shall not apply to the founding shareholders or their substitutes.10
|
4 |
Amendment No. 25
|
5 |
Amendment No. 9
|
6 |
Amendment No. 28
|
7 |
Amendment No. 31
|
8 |
Amendment No. 31
|
9 |
Amendment No. 25
|
10 |
Amendment No. 31
|
22. |
Placing a Charge on Means of Control
|
22A. |
Israeli Requirement and Holdings of Founding Shareholders or their Substitutes11
|
22A.1. |
The total cumulative holdings of the "Founding Shareholders or their Substitutes", as defined in Article 21.8, (including anyone that is an “Israeli Entity” as defined in Article 22.2A below, that purchased Means of Control from the Licensee and received the Minister’s approval to be considered a founding shareholder or their substitute from the date set by the Minister), and are bound by an agreement for the fulfillment of the provisions of Article 22A of the License (in this Article they will all be considered “Founding Shareholders or their Substitutes”) shall not be reduced to less than 26% of each of the Means of Control in the Licensee.
|
22A.2 |
The total cumulative holdings of "Israeli Entities", one or more, that are considered as one of the Founding Shareholders or their Substitutes, from the total holdings of Founding Shareholders or their Substitutes as set forth in Article 22A.1 above, shall not be reduced at all times to less than 5% of the total issued share capital and from each of the Means of Control in the Licensee. For this matter, the issued share capital of the Licensee shall be calculated by deducting the number of “Dormant Shares” held by the Licensee.
|
11 |
Amendment No. 31-Amendment No. 31 will come into effect upon completion of all of the obligations set forth in article 22A and no later than 30 June 2005, in accordance with the Ministry of Communications document 62/05-4031 dated 13 March 2005
|
22A.3 |
At least one tenth (10%) of the members of the Board of Directors of the Licensee shall be appointed by the Israeli Entities as set forth in Article 22A.2. Notwithstanding the above-mentioned, for this matter- if the Board of Directors of the Licensee shall consist of up to 14 members – at least one director shall be appointed by the Israeli entities as set forth in Article 22.2A above, if the Board of Directors of the Licensee shall consist of between 15 and 24 members-at least 2 directors shall be appointed by the Israeli entities as set forth in Article 22.2A above and so on and so forth.
|
22A.4 |
The Licensee's Board of Directors shall appoint from among its members that have security clearance and security compatibility to be determined by the General Security Service (hereinafter: “ Directors with Clearance”) a committee to be designated "the Committee for Security Matters", or CSM.
|
22A.5 |
Security matters that the Board of Directors or the Audit Committee of the Licensee shall be required to consider in accordance with the mandatory provisions of the Companies Law, 5759-1999, or in accordance with the mandatory provisions of any other law that applies to the Licensee shall be discussed, if they need to be discussed by the Board of Directors or the Audit Committee, only in the presence of Directors with Clearance. Directors that do not have security clearance shall not be allowed to participate in this Board of Directors or Audit Committee meeting and shall not be entitled to receive information or to review documents that relate to this matter. The legal quorum for such meetings shall include only Directors with Clearance.
|
22A.6 |
The shareholders at a general meeting shall not be entitled to assume, delegate, transfer or exercise any of the authorities granted to another organ in the company, regarding security matters.
|
22A.7 |
(a) The Minister shall appoint an observer for the Board of Directors and committee meetings, who has security clearance and security compatibility that will be determined by the General Security Services.
|
22A.8 |
The provisions of Article 22A of the License shall be adopted in the Articles of Association of the Licensee.
|
23. |
Prohibition of Cross-Ownership
|
23.1 |
The Licensee, an Office Holder or an Interested Party in the Licensee, as well as an Office Holder in an Interested Party in the Licensee, shall not hold, either directly or indirectly, five percent (5%) or more of any Means of Control in a Competing MRT Operator, and shall not serve as an Office Holder in a Competing MRT Operator or in an Interested Party in a Competing MRT Operator; for this matter, “Holding” includes holding as an agent.
|
23.2 |
Notwithstanding the provisions of Paragraph 23.1, the Minister may, based upon written request, permit an Office Holder in the Licensee to serve as an Office Holder in an Interested Party in a Competing MRT Operator, or permit an Office Holder in an Interested Party in the Licensee to serve as an Office Holder in a Competing MRT Operator or in an Interested Party in a Competing MRT Operator, if he is satisfied, that this will not harm the competition in MRT Services; the Minister may condition the granting of such permit on conditions that the Office Holder must fulfill for prevention of harm to the competition as aforesaid.
|
23.3 |
Notwithstanding the provisions of Paragraph 23.1, an Interested Party in the Licensee, which is a trust fund, an insurance company, an investment company or a pension fund, may hold up to ten percent (10%) of the Means of Control in a Competing MRT Operator, and an Interested Party in a Competing MRT Operator, which is a trust fund, an insurance company, an investment company or a pension fund, may hold up to ten percent (10%) of the Means of Control in the Licensee, provided it does not have a representative or an appointee on its behalf among the Office Holders of a Competing MRT Operator or of the Licensee, as the case may be, unless it is required to do so by law.
|
23.4 |
The Licensee, an Office Holder or an Interested Party in the Licensee, as well as an Office Holder in an Interested Party in the Licensee, will not control a Competing MRT Operator, and will not cause it, by any act or omission, to be controlled by a Competing MRT Operator or by an Office Holder or an Interested Party in a Competing MRT Operator, or by an Office Holder in an Interested Party in a Competing MRT Operator, or by a person or corporation that controls a Competing MRT Operator.
|
23.5 |
The rate of indirect holding in a corporation will be a product of the percentage of holdings in each stage of the chain of ownership, subject to what is set out in Paragraph 23.6; for example:
|
23.6 |
For the matter of this Paragraph and Paragraphs 14.1 (G) (6), (7), (8), (8a), (9) and 21.4, if a certain body (hereinafter: “the Controlling Body”) controls another body that has holdings, directly or indirectly, in the Licensee (hereinafter: “the Controlled Body”), the Controlling Body, and also any other body controlled by the Controlling Body, will be attributed with the rate of holdings in the Licensee that the Controlled Body has, directly or indirectly; according to the following examples:
|
(1) |
‘A’ holds 50% in Company ‘B’, and controls it;
|
(2) |
Company ‘B’ holds 50% in Company ‘C’, and controls it;
|
(3) |
Company ‘C’ holds 10% in the Licensee and does not control it;
|
(4) |
Therefore, notwithstanding that ‘A’s’ holdings in the Licensee in accordance with the instructions of Paragraph 5.6 are 2.5%, ‘A’ and also any body controlled by ‘A’ will be deemed as an Interested Party holding 10% in the Licensee.
|
(1) |
‘A’ holds 50% of Company ‘B’ and controls it;
|
(2) |
Company ‘B’ holds 40% of Company ‘C’ and controls it;
|
(3) |
Company ‘C’ holds 40% of Company ‘D’ and does not control it;
|
(4) |
Company ‘D’ holds 40% of the Licensee and does not control it;
|
(5) |
Therefore, ‘A’ and any body controlled by ‘A’ will be regarded as having a holding in the Licensee at the rate of holdings of Company ‘C’ in the Licensee, which is holdings of 16% (according to the method set out in Paragraph 23.5 for the calculation of the rate of indirect holdings in the absence of control), and in this manner, ‘A’ and any body controlled by ‘A’ is an Interested Party in the Licensee.
|
23.7 |
If a certain body has indirect holding in the Licensee, through two or more Interested Parties, then for the purpose of its definition as an Interested Party, and for the purpose of determining the rate of holding with regard to this Paragraph, the greatest indirect rate of holding will be taken into account, and also any rate of holding that derives from the chain of holdings through which the said holding body is attributed with the holdings of corporations controlled by it in accordance with the provisions of Paragraph 23.6; the rates of holdings that derive from two or more chains that will be taken into account as stated above, will be cumulative for the purpose of calculating the rate of holdings.
|
23.8 |
The Minister may, in response to a written request, permit an Interested Party in the Licensee to hold, either directly or indirectly, five percent (5%) or more in any of the Means of Control of a Competing MRT Operator, if the Minister is satisfied that this will not harm competition in the MRT field; 12the Minister may condition the granting of the said permit on a condition that the Interested Party in the Licensee or competing MRT Operator is an Interested Party merely by virtue of the provisions of Article 23.6 .
|
24. |
Prohibition of Conflict of Interests
|
12 |
Amendment No. 10
|
1. |
Approval of the re-appointment of Kesselman & Kesselman, independent certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited group, as the Company's auditor for the period ending at the close of the next annual general meeting;
|
2. |
Discussion of the auditor’s remuneration for the year ended December 31, 2017, as determined by the Audit Committee and by the Board of Directors, and the report of the Board of Directors with respect to the remuneration paid to the auditor and its affiliates for the year ended December 31, 2017; and
|
3. |
Discussion of the Company’s audited financial statements for the year ended December 31, 2017 and the report of the Board of Directors for such period.
|
4. |
to re-elect the following directors to the Company’s Board of Directors until the close of the next annual general meeting: Mr. Adam Chesnoff, Mr. Elon Shalev, Mr. Tomer Bar-Zeev, Mr. Sumeet Jaisinghani, Mr. Barak Pridor, Mr. Yoav Rubinstein, Mr. Arieh Saban, Mr. Yehuda Saban, Mr. Arie (Arik) Steinberg and Mr. Ori Yaron (the "Appointed Directors"), to approve the compensation of several directors; to approve that these directors will continue to benefit from the Company's existing D&O insurance policy; to approve that the directors who have indemnification and release letters will continue to benefit from the indemnification and release thereunder; and to approve and ratify (subject to the adoption of Resolution 5) that Mr. Tomer Bar-Zeev and Mr. Summet Jaisinghani will benefit from the indemnification and release under said resolutions.
|
5. |
Approval and Ratification of the grant of Indemnication and Release Letters to Mr. Tomer Bar-Zeev and Mr. Sumeet Jaisinghani;
|
(i)
|
“RESOLVED: to approve and ratify the Company’s undertaking to indemnify Mr. Tomer Bar-Zeev and to provide him with the Indemnification and Release Letter and that the Maximum Indemnity Amount is reasonable given the circumstances and that the indemnification events listed in Schedule I of the Indemnification and Release Letter are anticipated in light of Partner's current activities;
|
|
(ii) |
RESOLVED: to approve and ratify the Company’s undertaking to indemnify Mr. Mr. Sumeet Jaisinghani and to provide him with the Indemnification and Release Letter and that Maximum Indemnity Amount is reasonable given the circumstances and that the indemnification events listed in Schedule I of the Indemnification and Release Letter are anticipated in light of Partner's current activities; and
|
|
|
|
|
(iii) |
RESOLVED: these resolutions are in the best interest of the Company.”
|
6. |
Approval of re-appointment of Mr. Barry Ben Zeev (Woolfson) as an external director (Dahatz) for one additional and final term, approval of his remuneration, and approval that no change is made to his right to benefit from the Company’s D&O insurance policy and indemnification and release.
|
(i)
|
“RESOLVED: to re-appoint Mr. Barry Ben Zeev as an external director (Dahatz) of the Company for one additional and final term of three years in accordance with the Israeli Companies Law, commencing on October 28, 2018;
|
(ii)
|
RESOLVED: to approve the payment of the Remuneration and the reimbursement of expenses as set forth in the Remuneration Regulations to Mr. Barry Ben Zeev. In the event that options will be granted to Company directors, the Company will grant options to Mr. Barry Ben Zeev in a manner complying with the Remuneration Regulations, if and to the extent permitted by the Company's Compensation Policy at the relevant time. Mr. Ben Zeev will continue to benefit from the Company's D&O insurance policy (as in effect from time to time) and from his existing indemnification and release letters, which shall continue in full force and effect; and
|
(iii)
|
RESOLVED: these resolutions are in the best interest of the Company.”
|
7. |
Approval of a new equity incentive grant to the CEO
|
(i) |
“RESOLVED: to approve the New Equity Incentive Grant to the CEO, Mr. Isaac Benbenisti; and
|
(ii) |
RESOLVED: this resolution is in the best interest of the Company.”
|
Item No.
|
Subject of the Resolution
|
Vota
|
In respect of a transaction’s approval pursuant to sections 255, 267A and 272 to 275 (the majority required for which is not an ordinary majority), of the Israeli Companies Law)or in respect of an amendment to the Articles of Association regarding release, indemnification or insurance (section 262(b) of the Israeli Companies Law)- do you have a “Personal Interest” in the resolution, are you a “Controlling Party” in the Company, a “Senior Office Holder” or an “Institutional Investor”b?
|
|||
For
|
Against
|
Abstain
|
Yesc
|
No
|
||
1)
|
Approval of the re-appointment of Kesselman & Kesselman, independent certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited group, as the Company's auditor for the period ending at the close of the next annual general meeting.
This item is not subject to the Regulations Procedure.
|
Irrelevant
|
||||
2)
|
Discussion of the auditor’s remuneration for the year ended December 31, 2017, as determined by the Audit Committee and by the Board of Directors, and the report of the Board of Directors with respect to the remuneration paid to the auditor and its affiliates for the year ended December 31, 2017.
This item is not subject to the Regulations Procedure.
|
Irrelevant
|
Irrelevant
|
|||
3)
|
Discussion of the Company’s audited financial statements for the year ended December 31, 2017 and the report of the Board of Directors for such period.
This item is not subject to the Regulations Procedure.
|
Irrelevant
|
Irrelevant
|
Item No.
|
Subject of the Resolution
|
Vota
|
In respect of a transaction’s approval pursuant to sections 255, 267A and 272 to 275 (the majority required for which is not
an ordinary majority), of the Israeli Companies Law) or in respect of an amendment to the Articles of Association regarding release, indemnification or insurance (section 262(b) of the Israeli Companies Law) - do you have a “Personal Interest” in the resolution, are you a “Controlling Party” in the Company, a “Senior Office Holder” or an “Institutional Investor”b?
|
||||
For
|
Against
|
Abstain
|
Yesc
|
No
|
|||
4)
|
(i)
|
Approval of the re-election of Mr. Adam Chesnoff, Mr. Elon Shalev, Mr. Tomer Bar-Zeev, Mr. Sumeet Jaisinghani, Mr. Barak Pridor, Mr. Yoav Rubinstein, Mr. Arieh Saban, Mr. Yehuda Saban, Mr. Arie (Arik) Steinberg and Mr. Ori Yaron and to serve as directors of the Company until the close of the next annual general meeting, unless their office becomes vacant earlier in accordance with the provisions of the Israeli Companies Law and the Company’s Articles of Association.
This item is not subject to the Regulations Procedure.
|
|
||||
(ii)
|
(A) approval of the Compensation of Mr. Adam Chesnoff, Mr. Elon Shalev, Mr. Barak Pridor, Mr. Yoav Rubinstein, Mr. Arieh Saban, Mr. Yehuda Saban and Mr. Ori Yaron and approval and ratification of the Compensation of Mr. Tomer Bar-Zeev and Mr. Sumeet Jaisinghani; (B) approval and ratification of the reimbursement of Reasonable Expenses of each of the directors listed above in clause (A); (C) approval that the directors listed above in clause (A) will continue to benefit from the Company's existing D&O insurance policy; (D) approval and ratification that Mr. Tomer Bar-Zeev and Mr. Sumeet Jaisinghani will benefit from indemnification and release letters subject to the adoption of Resolution 5(i) and 5(ii) below; and (E) approval that the directors listed above in clause (A) who have indemnification and release letters will continue to benefit from their existing indemnification and release letters which will continue in full force and effect;
This item is subject to the Regulations Procedure.
|
||||||
(iii)
|
(A) approval of the Compensation of Ms. Osnat Ronen and Mr. Arie Steinberg; (B) approval and ratification of the reimbursement of Reasonable Expenses of Ms. Osnat Ronen and Mr. Arie Steinberg; (C) approval that Ms. Osnat Ronen and Mr. Arie Steinberg will continue to benefit from the Company's existing D&O insurance policy; and (D) approval that Ms. Osnat Ronen and Mr. Arie Steinberg who have indemnification and release letters will continue to benefit from them which will continue in full force and effect.
This item is not subject to the Regulations Procedure.
|
|
Item No.
|
Subject of the Resolution
|
Vota
|
In respect of a transaction’s approval pursuant to sections 255, 267A and 272 to 275 (the majority required for which is not
an ordinary majority), of the Israeli Companies Law) or in respect of an amendment to the Articles of Association regarding release, indemnification or insurance (section 262(b) of the Israeli Companies Law) - do you have a “Personal Interest” in the resolution, are you a “Controlling Party” in the Company, a “Senior Office Holder” or an “Institutional Investor”b?
|
||||
For
|
Against
|
Abstain
|
Yesc
|
No | |||
5)
|
(i)
|
Approval and Ratification of the grant of an indemnification and release letter to Mr. Tomer Bar Zeev.
This item is subject to the Regulations Procedure.
|
|||||
(ii)
|
Approval and Ratification of the grant of an indemnification and release letter to Mr. Sumeet Jaisinghani.
This item is subject to the Regulations Procedure
|
||||||
6)
|
Approval of re-appointment of Mr. Barry Ben Zeev (Woolfson) as an external director (Dahatz) for one additional and final term, approval of his remuneration, and approval that no change is made to his right to benefit from the Company’s D&O insurance policy and indemnification and release
This item is subject to the Regulations Procedure.
|
||||||
7)
|
Approval of a New Equity Incentive Grant to the CEO
This item is subject to the Regulations Procedure.
|
|
Signature
Name (Print): ___________
Title: __________________
Date: __________________
|
e |
Under certain licenses granted, directly or indirectly, to Partner, approval of, or notice to, the Minister of Communications of the State of Israel may be required for holding of 5% or more of Partner's means of control.
|
To:
|
Partner Communications Company Ltd. (the “Company”)
|
Attn:
|
Hadar Vismunski-Weinberg, Adv., Company Secretary
|
1 |
Name of shareholder.
|
2 |
A shareholder is entitled to give several Deeds of Authorization, each of which refers to a different quantity of Ordinary Shares of the Company held by the shareholder, so long as the shareholder shall not give Deeds of Authorization with respect to an aggregate number of Ordinary Shares exceeding the total number of shares held by him.
|
3 |
In the event that the proxy does not hold an Israeli Identification number, indicate a passport number, if any, and the name of the country in which the passport was issued.
|
4 |
Kindly provide details regarding the nature of your “Personal Interest” in the resolution, why do you constitute a “Controlling Party” in the Company, you are a “Senior Office Holder” or an “Institutional Investor” (as the case may be), at the designated space below the table (on page 7). “Personal Interest” is defined in Section 1 of the Israeli Companies Law (1999), as amended (the “Israeli Companies Law”) as a person’s personal interest in an act or a transaction of a company, including, without limitation, the personal interest of a person's relative and the personal interest of an entity in which the person or the person's relative is an interested party. Holding shares in the applicable company does not give rise to a “Personal Interest”. “Personal Interest” includes, without limitation, a personal interest of a person voting by proxy which was given by another person, even if the other person does not have a personal interest, and a person voting on behalf of a person having a personal interest will be deemed as having a personal interest, whether the voting discretion is in the voter’s hands or not. The Israeli Companies Law refers to the definition of “Control” in Section 1 of the Israeli Securities Law (1968), as amended, defining "Control" as the ability to direct the activity of a company, except for ability stemming only from being a director or holding another position in that company, and it is presumed that a person is controlling a company if said person "holds" (as defined therein) at least half of (i) the right to vote in the shareholders general meeting; or (ii) the right to appoint the directors or the general manager of that company. For approval of the resolutions regarding the detailed items, any shareholders holding 25% or more of the voting rights in a company will be deemed a “Controlling Party”. Two or more persons holding voting rights in a company whereas each of them has a personal interest in approving a certain transaction would be deemed “holding together”. According to section 37 (d) of the Securities Law, a “Senior Office Holder” is, generally, a general manager, chief executive officer, deputy managing director, deputy director general, all fulfilling such a role in the company even if his title is different, a director, or manager directly subordinated to the general manager; as well as chairman of the board, an alternate director, an individual appointed under section 236 of the Israeli Companies Law on behalf of the corporation who is a director, controller, an internal auditor, independent authorized signatory, and anyone fulfilling such a role, even if his job title is different, and a Senior Office Holder of a corporation controlled by the corporation, which has a significant impact on the corporation and any individual employed by a corporation in another position, holding five percent or more of the nominal value of the issued share capital or voting rights. “Institutional Investor” - shall have the meaning defined in section 1 of the Supervisory Regulations Control of Financial Services (Provident Funds) (Participation of a Managing Company at a General Meeting), 2009, and a managing company of a Joint Investment Trust Fund as defined in the Joint Investment Trust Law, 1994.
|
Item No.
|
Subject of the Resolution
|
Vote5
|
In respect of a transaction’s approval pursuant to sections 255, 267A and 272 to 275 (the majority required for which is not
an ordinary majority), of the Israeli Companies Law) or in respect of an amendment to the Articles of Association regarding release, indemnification or insurance (section 262(b) of the Israeli Companies Law) - do you have a “Personal Interest” in the resolution, are you a “Controlling Party” in the Company, a “Senior Office Holder” or an “Institutional Investor”6?
|
For
|
Against
|
Abstain
|
Yes7
|
No
|
||
1)
|
Approval of the re-appointment of Kesselman & Kesselman, independent certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited group, as the Company's auditor for the period ending at the close of the next annual general meeting.
This item is not subject to the Regulations Procedure.
|
Irrelevant
|
||||
2)
|
Discussion of the auditor’s remuneration for the year ended December 31, 2017, as determined by the Audit Committee and by the Board of Directors, and the report of the Board of Directors with respect to the remuneration paid to the auditor and its affiliates for the year ended December 31, 2017.
This item is not subject to the Regulations Procedure.
|
Irrelevant
|
Irrelevant
|
|||
3)
|
Discussion of the Company’s audited financial statements for the year ended December 31, 2017 and the report of the Board of Directors for such period.
This item is not subject to the Regulations Procedure.
|
Irrelevant
|
Irrelevant
|
Item No.
|
Subject of the Resolution
|
Vote5
|
In respect of a transaction’s approval pursuant to sections 255, 267A and 272 to 275 (the majority required for which is not
an ordinary majority), of the Israeli Companies Law) or in respect of an amendment to the Articles of Association regarding release, indemnification or insurance (section 262(b) of the Israeli Companies Law) - do you have a “Personal Interest” in the resolution, are you a “Controlling Party” in the Company, a “Senior Office Holder” or an “Institutional Investor”6?
|
For
|
Against
|
Abstain
|
Yes7
|
No
|
4)
|
(i)
|
Approval of the re-election of Mr. Adam Chesnoff, Mr. Elon Shalev, Mr. Tomer Bar-Zeev, Mr. Sumeet Jaisinghani, Mr. Barak Pridor, Mr. Yoav Rubinstein, Mr. Arieh Saban, Mr. Yehuda Saban, Mr. Arie (Arik) Steinberg and Mr. Ori Yaron, to serve as directors of the Company until the close of the next annual general meeting, unless their office becomes vacant earlier in accordance with the provisions of the Israeli Companies Law and the Company’s Articles of Association.
This item is not subject to the Regulations Procedure.
|
|||||
(ii)
|
(A) approval of the Compensation of Mr. Adam Chesnoff, Mr. Elon Shalev, Mr. Barak Pridor, Mr. Yoav Rubinstein, Mr. Arieh Saban, Mr Yehuda Saban and Mr. Ori Yaron, and approval and ratification of the Compensation of Mr. Tomer Bar-Zeev and Mr. Sumeet Jaisinghani; (B) approval and ratification of the reimbursement of Reasonable Expenses of each of the directors listed above in clause (A); (C) approval that the directors listed above in clause (A) will continue to benefit from the Company's existing D&O insurance policy; (D) approval and ratification that Mr. Tomer Bar-Zeev and Mr. Sumeet Jaisinghani will benefit from indemnification and release letters subject to the adoption of Resolution 5 below; and (E) to approve that the directors listed aboved in clause (A) who have indemnification letters will continue to benefit from their existing indemnification and release letters which will continue in full force and effect;
This item is subject to the Regulations Procedure.
|
||||||
(iii)
|
(A) approval of the Compensation of Ms. Osnat Ronen and Mr. Arie Steinberg; (B) approval and ratification of the reimbursement of Reasonable Expenses of Ms. Osnat Ronen and Mr. Arie Steinberg; (C) approval that Ms. Osnat Ronen and Mr. Arie Steinberg will continue to benefit from the Company's existing D&O insurance policy; and (D) approval that Ms. Osnat Ronen and Mr. Arie Steinberg who have indemnification and release letters will continue to benefit from them which will continue in full force and effect.
This item is not subject to the Regulations Procedure.
|
Irrelevant
|
Item No.
|
Subject of the Resolution
|
Vote5
|
In respect of a transaction’s approval pursuant to sections 255, 267A and 272 to 275 (the majority required for which is not
an ordinary majority), of the Israeli Companies Law) or in respect of an amendment to the Articles of Association regarding release, indemnification or insurance (section 262(b) of the Israeli Companies Law) - do you have a “Personal Interest” in the resolution, are you a “Controlling Party” in the Company, a “Senior Office Holder” or an “Institutional Investor”6?
|
For
|
Against
|
Abstain
|
Yes7
|
No
|
5)
|
(i)
|
Approval and Ratification of the grant of an indemnification and release letter to Mr. Tomer Bar Zeev.
This item is subject to the Regulations Procedure.
|
|||||
(ii)
|
Approval and Ratification of the grant of an indemnification and release letter to Mr. Sumeet Jaisinghani.
This item is subject to the Regulations Procedure.
|
||||||
6)
|
Approval of re-appointment of Mr. Barry Ben Zeev (Woolfson) as an external director (Dahatz) for one additional and final term, approval of his remuneration, and approval that no change is made to his right to benefit from the Company’s D&O insurance policy and indemnification and release
This item is subject to the Regulations Procedure.
|
||||||
7)
|
Approval of a new equity incentive grant to the CEO.
This item is subject to the Regulations Procedure.
|
☐
|
Yes. I approve the declaration below.
|
☐
|
No. I do not approve the declaration below. I hold, together with others, ________ Ordinary Shares of Partner.
|
Date: _____________
|
|
______________________________________________ | |||||
Signature
|
|||||||
Name (print):_______________
|
|||||||
Title: _____________________
|
8 |
In the event that the shareholder is an “Interested Party,” as defined in the License, voting in a different manner with respect to each part of the shareholder's Ordinary Shares, a separate Deed of Authorization should be filed for each quantity of Ordinary Shares in respect of which the shareholder intends to vote differently.
|
9 |
A translation of sections 21-24 of the License is attached as Annex “D” to the Proxy Statement distributed with this Deed of Authorization.
|
10 |
Under certain licenses granted, directly or indirectly, to Partner, approval of, or notice to, the Minister of Communications of the State of Israel may be required for holding of 5% or more of Partner's means of control.
|
Partner Communications Company Ltd.
|
|||
By:
|
/s/ Tamir Amar
|
||
Name:
|
Tamir Amar
|
||
Title:
|
Chief Financial Officer
|